Expression	O
of	O
the	O
chemokine	B-protein
receptor	I-protein
BLR2/EBI1	B-protein
is	O
specifically	O
transactivated	O
by	O
Epstein-Barr	B-protein
virus	I-protein
nuclear	I-protein
antigen	I-protein
2	I-protein
.	O

In	O
our	O
attempt	O
to	O
identify	O
chemokine	B-protein
receptors	I-protein
that	O
are	O
related	O
to	O
Burkitt	B-protein
's	I-protein
lymphoma	I-protein
receptor	I-protein
1	I-protein
(	O
BLR1	B-protein
)	O
and	O
are	O
expressed	O
in	O
activated	B-cell_type
lymphocytes	I-cell_type
we	O
used	O
RT-PCR	O
resulting	O
in	O
the	O
isolation	O
of	O
a	O
cDNA	O
encoding	O
a	O
seven	B-protein
transmembrane	I-protein
receptor	I-protein
termed	O
BLR2	B-protein
.	O

The	O
protein	O
shows	O
significant	O
sequence	O
similarities	O
to	O
the	O
family	O
of	O
G-protein	B-protein
coupled	I-protein
chemokine	I-protein
receptors	I-protein
and	O
turned	O
out	O
to	O
be	O
identical	O
to	O
the	O
recently	O
described	O
receptor	B-protein
EBI1	I-protein
.	O

Northern	O
blot	O
analysis	O
revealed	O
that	O
BLR2	B-RNA
mRNA	I-RNA
could	O
be	O
highly	O
stimulated	O
in	O
mitogen-	B-cell_line
and	I-cell_line
anti-CD3-treated	I-cell_line
peripheral	I-cell_line
blood	I-cell_line
lymphocytes	I-cell_line
.	O

BLR2-specific	B-RNA
mRNA	I-RNA
could	O
be	O
detected	O
in	O
all	O
Epstein-Barr	B-cell_line
virus	I-cell_line
positive	I-cell_line
B	I-cell_line
cell	I-cell_line
lines	I-cell_line
.	O

We	O
show	O
that	O
transcription	O
of	O
the	O
BLR2	B-DNA
gene	I-DNA
could	O
be	O
specifically	O
induced	O
in	O
Epstein-Barr	B-cell_line
virus	I-cell_line
negative	I-cell_line
BL	I-cell_line
41	I-cell_line
cells	I-cell_line
via	O
estrogen-mediated	O
activation	O
of	O
Epstein-Barr	B-protein
virus	I-protein
nuclear	I-protein
antigen	I-protein
2	I-protein
,	O
a	O
key	O
regulator	O
of	O
viral	B-DNA
and	I-DNA
cellular	I-DNA
genes	I-DNA
in	O
immortalized	B-cell_line
B	I-cell_line
cells	I-cell_line
.	O

Our	O
data	O
suggest	O
an	O
involvement	O
of	O
BLR2	B-protein
in	O
the	O
regulation	O
of	O
migration	O
in	O
activated	B-cell_type
lymphocytes	I-cell_type
and	O
in	O
viral	O
pathogenesis	O
.	O

MOLECULAR	NULL
AND	NULL
CELLULAR	NULL
BIOLOGY	NULL
,	NULL
Sept.	NULL
1996	NULL
,	NULL
p.	NULL
4656-4664	NULL
0270-7306/96/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

16	NULL
,	NULL
No	NULL
.	NULL

9	NULL
Interaction	NULL
of	NULL
the	NULL
Human	NULL
T-Cell	NULL
Lymphotropic	NULL
Virus	NULL
Type	NULL
1	NULL
Tax	NULL
Transactivator	NULL
with	NULL
Transcription	NULL
Factor	NULL
IIA	NULL
KAREN	NULL
E.	NULL
CLEMENS	NULL
,	NULL
``	NULL
GRAZIELLA	NULL
PIRAS	NULL
,	NULL
'	NULL
MICHAEL	NULL
F.	NULL
RADONOVICH	NULL
,	NULL
'	NULL
KYEONG	NULL
SOOK	NULL
CHOI	NULL
,	NULL
!	NULL

JANET	NULL
F.	NULL
DUVALL	NULL
,	NULL
*	NULL
JEFF	NULL
DEJONG	NULL
,	NULL
``	NULL
ROBERT	NULL
ROEDER	NULL
,	NULL
``	NULL
anp	NULL
JOHN	NULL
N.	NULL
BRADY'*	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Virology	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
Bethesda	NULL
,	NULL
Maryland	NULL
20892-5055	NULL
``	NULL
;	NULL
Department	NULL
of	NULL
Biology	NULL
,	NULL
University	NULL
of	NULL
Texas	NULL
at	NULL
Dallas	NULL
,	NULL
Richardson	NULL
,	NULL
Texas	NULL
75080	NULL
;	NULL
and	NULL
The	NULL
Rockefeller	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
New	NULL
York	NULL
10021	NULL
``	NULL
Received	NULL
8	NULL
April	NULL
1996/Returned	NULL
for	NULL
modification	NULL
17	NULL
May	NULL
1996/Accepted	NULL
3	NULL
June	NULL
1996	NULL
The	NULL
Tax	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
is	NULL
a	NULL
40-kDa	NULL
transcriptional	NULL
activator	NULL
which	NULL
is	NULL
critical	NULL
for	NULL
HTLV-1	NULL
gene	NULL
regulation	NULL
and	NULL
virus-induced	NULL
cellular	NULL
transformation	NULL
.	NULL

Tax	NULL
is	NULL
localized	NULL
to	NULL
the	NULL
DNA	NULL
through	NULL
its	NULL
interaction	NULL
with	NULL
the	NULL
site-specific	NULL
activators	NULL
cyclic	NULL
AMP-responsive	NULL
element-binding	NULL
protein	NULL
,	NULL
NF-B	NULL
,	NULL
and	NULL
serum	NULL
response	NULL
factor	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
that	NULL
the	NULL
recruitment	NULL
of	NULL
Tax	NULL
to	NULL
the	NULL
DNA	NULL
positions	NULL
Tax	NULL
for	NULL
interaction	NULL
with	NULL
the	NULL
basal	NULL
transcriptional	NULL
machinery	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
several	NULL
independent	NULL
assays	NULL
,	NULL
we	NULL
now	NULL
report	NULL
a	NULL
physical	NULL
and	NULL
functional	NULL
interaction	NULL
between	NULL
Tax	NULL
and	NULL
the	NULL
transcription	NULL
factor	NULL
,	NULL
TFIIA	NULL
.	NULL

First	NULL
,	NULL
Tax	NULL
was	NULL
found	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
35-kDa	NULL
(	NULL
«	NULL
)	NULL
subunit	NULL
of	NULL
TFIIA	NULL
in	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
interaction	NULL
system	NULL
.	NULL

Importantly	NULL
,	NULL
two	NULL
previously	NULL
characterized	NULL
mutants	NULL
with	NULL
point	NULL
mutations	NULL
in	NULL
Tax	NULL
,	NULL
M32	NULL
(	NULL
Y196A	NULL
,	NULL
K1978	NULL
)	NULL
and	NULL
M41	NULL
(	NULL
H287A	NULL
,	NULL
P288S	NULL
)	NULL
,	NULL
which	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
defective	NULL
in	NULL
Tax-activated	NULL
transcription	NULL
were	NULL
unable	NULL
to	NULL
interact	NULL
with	NULL
TFIIA	NULL
in	NULL
this	NULL
assay	NULL
.	NULL

Second	NULL
,	NULL
a	NULL
glutathione-S-transferase	NULL
(	NULL
GST	NULL
)	NULL
affinity-binding	NULL
assay	NULL
showed	NULL
that	NULL
the	NULL
interaction	NULL
of	NULL
holo-TFIIA	NULL
with	NULL
GST-Tax	NULL
was	NULL
20-fold	NULL
higher	NULL
than	NULL
that	NULL
observed	NULL
with	NULL
either	NULL
the	NULL
GST-Tax	NULL
M32	NULL
activation	NULL
mutant	NULL
or	NULL
the	NULL
GST	NULL
control	NULL
.	NULL

Third	NULL
,	NULL
a	NULL
coimmunoprecipitation	NULL
assay	NULL
showed	NULL
that	NULL
in	NULL
HTLV-1-infected	NULL
human	NULL
T	NULL
lymphocytes	NULL
,	NULL
Tax	NULL
and	NULL
TFIIA	NULL
were	NULL
associated	NULL
.	NULL

Finally	NULL
,	NULL
TFIIA	NULL
facilitates	NULL
Tax	NULL
transactivation	NULL
in	NULL
vitro	NULL
and	NULL
in	NULL
vivo	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
studies	NULL
showed	NULL
reduced	NULL
levels	NULL
of	NULL
Tax-activated	NULL
transcription	NULL
in	NULL
cell	NULL
extracts	NULL
depleted	NULL
of	NULL
TFIIA	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
transfection	NULL
of	NULL
human	NULL
T	NULL
lymphocytes	NULL
with	NULL
TFIIA	NULL
expression	NULL
vectors	NULL
enhanced	NULL
Tax-activated	NULL
transcription	NULL
of	NULL
an	NULL
HTLV-1	NULL
long	NULL
terminal	NULL
repeat-chloramphenicol	NULL
acetyltransferase	NULL
reporter	NULL
con-struct	NULL
.	NULL

Our	NULL
study	NULL
suggests	NULL
that	NULL
the	NULL
interaction	NULL
of	NULL
Tax	NULL
with	NULL
the	NULL
transcription	NULL
factor	NULL
TFIIA	NULL
may	NULL
play	NULL
a	NULL
role	NULL
in	NULL
Tax-mediated	NULL
transcriptional	NULL
activation	NULL
.	NULL

Human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
is	NULL
associated	NULL
with	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
and	NULL
the	NULL
degenerative	NULL
neuro-muscular	NULL
disease	NULL
tropical	NULL
spastic	NULL
paraparesis/HTLV-1-associ-ated	NULL
myelopathy	NULL
(	NULL
28	NULL
,	NULL
66	NULL
,	NULL
72	NULL
,	NULL
108	NULL
)	NULL
.	NULL

HTLV-1	NULL
encodes	NULL
a	NULL
40-kDa	NULL
protein	NULL
,	NULL
Tax	NULL
,	NULL
which	NULL
transforms	NULL
rodent	NULL
fibroblasts	NULL
(	NULL
90	NULL
)	NULL
,	NULL
immortalizes	NULL
normal	NULL
human	NULL
T	NULL
cells	NULL
(	NULL
34	NULL
)	NULL
,	NULL
and	NULL
can	NULL
induce	NULL
a	NULL
leukemia-like	NULL
disease	NULL
in	NULL
transgenic	NULL
mice	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Tax	NULL
is	NULL
critical	NULL
for	NULL
HTLV-1	NULL
gene	NULL
regulation	NULL
(	NULL
44	NULL
,	NULL
68	NULL
,	NULL
75	NULL
,	NULL
85	NULL
)	NULL
and	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
modulate	NULL
the	NULL
expression	NULL
of	NULL
a	NULL
number	NULL
of	NULL
cellular	NULL
genes	NULL
which	NULL
include	NULL
genes	NULL
encoding	NULL
cytokines	NULL
(	NULL
interleukin-1	NULL
[	NULL
IL-1	NULL
]	NULL
,	NULL
IL-2	NULL
,	NULL
IL-3	NULL
,	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
and	NULL
granulocyte-macrophage	NULL
colony-stimulat-ing	NULL
factor	NULL
)	NULL
(	NULL
35	NULL
,	NULL
37	NULL
,	NULL
60	NULL
,	NULL
61	NULL
,	NULL
65	NULL
,	NULL
83	NULL
,	NULL
100	NULL
,	NULL
103	NULL
)	NULL
,	NULL
genes	NULL
encoding	NULL
cytokine	NULL
receptors	NULL
(	NULL
IL-2	NULL
receptor	NULL
a	NULL
)	NULL
(	NULL
14	NULL
,	NULL
15	NULL
,	NULL
43	NULL
,	NULL
52	NULL
,	NULL
76	NULL
)	NULL
,	NULL
proto-oncogenes	NULL
(	NULL
c-fos	NULL
,	NULL
c-myc	NULL
)	NULL
(	NULL
2	NULL
,	NULL
20	NULL
,	NULL
23-25	NULL
)	NULL
,	NULL
and	NULL
genes	NULL
encoding	NULL
lymphotoxin	NULL
(	NULL
69	NULL
,	NULL
70	NULL
)	NULL
,	NULL
parathyroid	NULL
hormone-related	NULL
protein	NULL
(	NULL
18	NULL
,	NULL
98	NULL
)	NULL
,	NULL
and	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
I	NULL
proteins	NULL
(	NULL
77	NULL
)	NULL
.	NULL

The	NULL
deregulation	NULL
of	NULL
these	NULL
Tax-responsive	NULL
cellular	NULL
genes	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
HTLV-1	NULL
transformation	NULL
.	NULL

The	NULL
HTLV-1	NULL
Tax	NULL
protein	NULL
is	NULL
able	NULL
to	NULL
modulate	NULL
gene	NULL
expression	NULL
by	NULL
several	NULL
independent	NULL
mechanisms	NULL
.	NULL

Tax	NULL
can	NULL
induce	NULL
the	NULL
nuclear	NULL
localization	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
factors	NULL
c-rel	NULL
,	NULL
p65	NULL
,	NULL
p50	NULL
,	NULL
and	NULL
p52	NULL
(	NULL
14	NULL
,	NULL
46	NULL
,	NULL
51	NULL
,	NULL
88	NULL
)	NULL
by	NULL
overriding	NULL
the	NULL
inhibitory	NULL
function	NULL
of	NULL
IxBa	NULL
(	NULL
38	NULL
,	NULL
46	NULL
,	NULL
51	NULL
,	NULL
56	NULL
,	NULL
62	NULL
,	NULL
88	NULL
)	NULL
.	NULL

Recent	NULL
reports	NULL
suggest	NULL
that	NULL
Tax	NULL
activation	NULL
of	NULL
the	NULL
NF-kB	NULL
pathway	NULL
involves	NULL
the	NULL
induction	NULL
of	NULL
phosphorylation	NULL
and	NULL
proteasome-mediated	NULL
degradation	NULL
of	NULL
IxBa	NULL
(	NULL
56	NULL
,	NULL
62	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Tax	NULL
interacts	NULL
with	NULL
transcription	NULL
factors	NULL
such	NULL
as	NULL
the	NULL
serum	NULL
response	NULL
factor	NULL
(	NULL
23	NULL
,	NULL
25	NULL
)	NULL
,	NULL
several	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Virology	NULL
,	NULL
National	NULL
Cancer	NULL
Institute	NULL
,	NULL
Bldg	NULL
.	NULL

41	NULL
,	NULL
Rm	NULL
.	NULL

B403	NULL
,	NULL
Bethesda	NULL
,	NULL
MD	NULL
20892-5055	NULL
.	NULL

Phone	NULL
:	NULL
(	NULL
301	NULL
)	NULL
496-6201	NULL
.	NULL

Fax	NULL
:	NULL
(	NULL
301	NULL
)	NULL
496-4951	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
bradyj	NULL
@	NULL
dced41.nci.nih.gov	NULL
.	NULL

4656	NULL
NF-	NULL
«	NULL
B	NULL
family	NULL
members	NULL
(	NULL
6	NULL
,	NULL
38	NULL
,	NULL
62	NULL
,	NULL
89	NULL
)	NULL
,	NULL
and	NULL
the	NULL
bZIP	NULL
protein	NULL
,	NULL
cyclic	NULL
AMP	NULL
element-binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
(	NULL
1	NULL
,	NULL
33	NULL
,	NULL
104	NULL
,	NULL
105	NULL
)	NULL
,	NULL
indirectly	NULL
forming	NULL
a	NULL
complex	NULL
with	NULL
the	NULL
template	NULL
DNA	NULL
.	NULL

Studies	NULL
have	NULL
further	NULL
demonstrated	NULL
that	NULL
Tax	NULL
binds	NULL
to	NULL
the	NULL
DNA-binding	NULL
basic	NULL
segment	NULL
of	NULL
the	NULL
bZIP	NULL
proteins	NULL
,	NULL
enhancing	NULL
their	NULL
binding	NULL
affinity	NULL
and	NULL
interaction	NULL
with	NULL
Tax-responsive	NULL
,	NULL
non-consensus	NULL
CRE	NULL
sites	NULL
(	NULL
1	NULL
,	NULL
4	NULL
,	NULL
5	NULL
,	NULL
22	NULL
,	NULL
71	NULL
,	NULL
96	NULL
,	NULL
111	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
when	NULL
fused	NULL
to	NULL
a	NULL
Gal4	NULL
DNA-binding	NULL
domain	NULL
,	NULL
Tax	NULL
was	NULL
able	NULL
to	NULL
activate	NULL
transcription	NULL
from	NULL
a	NULL
minimal	NULL
promoter	NULL
,	NULL
suggesting	NULL
that	NULL
Tax	NULL
possesses	NULL
an	NULL
intrinsic	NULL
transactivation	NULL
function	NULL
(	NULL
26	NULL
,	NULL
79	NULL
)	NULL
.	NULL

On	NULL
the	NULL
basis	NULL
of	NULL
these	NULL
studies	NULL
,	NULL
it	NULL
is	NULL
thought	NULL
that	NULL
after	NULL
localizing	NULL
to	NULL
the	NULL
DNA	NULL
through	NULL
interaction	NULL
with	NULL
site-specific	NULL
activators	NULL
,	NULL
Tax	NULL
may	NULL
affect	NULL
the	NULL
dynamics	NULL
of	NULL
transcription	NULL
through	NULL
contact	NULL
with	NULL
the	NULL
basal	NULL
transcription	NULL
machinery	NULL
.	NULL

RNA	NULL
polymerase	NULL
II-directed	NULL
transcription	NULL
requires	NULL
the	NULL
assembly	NULL
of	NULL
a	NULL
large	NULL
preinitiation	NULL
transcription	NULL
complex	NULL
composed	NULL
of	NULL
the	NULL
basic	NULL
transcription	NULL
factors	NULL
TFIIA	NULL
,	NULL
TFIIB	NULL
,	NULL
TFIID	NULL
(	NULL
TATA-binding	NULL
protein	NULL
[	NULL
TBP	NULL
]	NULL
and	NULL
TBP-associated	NULL
factors	NULL
[	NULL
TAFs	NULL
]	NULL
)	NULL
,	NULL
TFHIF	NULL
,	NULL
TFIIH	NULL
,	NULL
and	NULL
TFIIE	NULL
(	NULL
reviewed	NULL
in	NULL
references	NULL
81	NULL
and	NULL
110	NULL
)	NULL
.	NULL

Transcriptionally	NULL
competent	NULL
preinitiation	NULL
complexes	NULL
formed	NULL
in	NULL
vitro	NULL
assemble	NULL
by	NULL
an	NULL
ordered	NULL
multistep	NULL
pathway	NULL
beginning	NULL
with	NULL
the	NULL
binding	NULL
of	NULL
TFIID	NULL
to	NULL
the	NULL
TATA	NULL
box	NULL
at	NULL
the	NULL
promoter	NULL
region	NULL
on	NULL
the	NULL
DNA	NULL
template	NULL
(	NULL
7	NULL
,	NULL
63	NULL
,	NULL
94	NULL
)	NULL
.	NULL

TFIIA	NULL
,	NULL
which	NULL
directly	NULL
binds	NULL
TBP	NULL
,	NULL
is	NULL
thought	NULL
to	NULL
enter	NULL
the	NULL
complex	NULL
at	NULL
an	NULL
early	NULL
point	NULL
in	NULL
the	NULL
assembly	NULL
process	NULL
after	NULL
or	NULL
simultaneously	NULL
with	NULL
the	NULL
TFIID-DNA	NULL
nucleation	NULL
step	NULL
(	NULL
73	NULL
,	NULL
97	NULL
,	NULL
109	NULL
,	NULL
110	NULL
)	NULL
.	NULL

The	NULL
assembly	NULL
process	NULL
then	NULL
continues	NULL
with	NULL
the	NULL
subsequent	NULL
association	NULL
of	NULL
TFIIB	NULL
,	NULL
RNA	NULL
polymerase	NULL
II	NULL
complexed	NULL
to	NULL
TFIIF	NULL
,	NULL
TFIIE	NULL
,	NULL
and	NULL
TFIIH	NULL
(	NULL
109	NULL
)	NULL
.	NULL

Transcriptional	NULL
activators	NULL
exhibit	NULL
activation	NULL
domain-dependent	NULL
interactions	NULL
with	NULL
TBP	NULL
,	NULL
TFIIB	NULL
,	NULL
TFIIF	NULL
,	NULL
TFIIH	NULL
,	NULL
and	NULL
TAFs	NULL
(	NULL
9	NULL
,	NULL
11-13	NULL
,	NULL
32	NULL
,	NULL
41	NULL
,	NULL
54	NULL
,	NULL
86	NULL
,	NULL
91	NULL
,	NULL
95	NULL
,	NULL
101	NULL
,	NULL
112	NULL
)	NULL
and	NULL
may	NULL
function	NULL
by	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
increasing	NULL
the	NULL
number	NULL
of	NULL
functional	NULL
preinitiation	NULL
complexes	NULL
(	NULL
12	NULL
,	NULL
39	NULL
,	NULL
54	NULL
,	NULL
109	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
suggest	NULL
that	NULL
TFIIA	NULL
may	NULL
also	NULL
be	NULL
targeted	NULL
by	NULL
activators	NULL
and	NULL
coactivators	NULL
(	NULL
27	NULL
,	NULL
49	NULL
,	NULL
53	NULL
,	NULL
67	NULL
)	NULL
.	NULL

TFIIA	NULL
was	NULL
initially	NULL
observed	NULL
to	NULL
preclude	NULL
the	NULL
association	NULL
of	NULL
protein	NULL
inhibitors	NULL
with	NULL
TBP-promoter	NULL
complexes	NULL
,	NULL
whose	NULL
interaction	NULL
with	NULL
TBP	NULL
can	NULL
prevent	NULL
the	NULL
assembly	NULL
of	NULL
functional	NULL
preinitiation	NULL
complexes	NULL
(	NULL
3	NULL
,	NULL
42	NULL
,	NULL
48	NULL
,	NULL
50	NULL
,	NULL
58	NULL
,	NULL
59	NULL
,	NULL
99	NULL
)	NULL
.	NULL

However	NULL
,	NULL
additional	NULL
studies	NULL
in	NULL
which	NULL
highly	NULL
purified	NULL
and	NULL
potentially	NULL
in-hibitor-free	NULL
transcription	NULL
factors	NULL
were	NULL
used	NULL
showed	NULL
a	NULL
TFIIA	NULL
enhancement	NULL
of	NULL
activated	NULL
transcription	NULL
suggesting	NULL
a	NULL
direct	NULL
role	NULL
for	NULL
TFIIA	NULL
in	NULL
the	NULL
activation	NULL
process	NULL
(	NULL
87	NULL
)	NULL
.	NULL

In	NULL
these	NULL
and	NULL
other	NULL
systems	NULL
,	NULL
TFIIA	NULL
is	NULL
also	NULL
able	NULL
to	NULL
enhance	NULL
basal	NULL
transcription	NULL
reconstituted	NULL
with	NULL
TBP	NULL
(	NULL
16	NULL
,	NULL
48	NULL
,	NULL
55	NULL
,	NULL
87	NULL
)	NULL
.	NULL

As	NULL
pointed	NULL
out	NULL
by	NULL
Goodrich	NULL
et	NULL
al	NULL
.	NULL

(	NULL
31a	NULL
)	NULL
,	NULL
the	NULL
prevalence	NULL
of	NULL
promoter	NULL
diversity	NULL
suggests	NULL
that	NULL
interactions	NULL
between	NULL
general	NULL
transcription	NULL
factors	NULL
,	NULL
transcriptional	NULL
activators	NULL
,	NULL
and	NULL
the	NULL
DNA	NULL
template	NULL
may	NULL
vary	NULL
from	NULL
promoter	NULL
to	NULL
promoter	NULL
.	NULL

It	NULL
is	NULL
speculated	NULL
that	NULL
a	NULL
critical	NULL
rate-limiting	NULL
step	NULL
in	NULL
activator-dependent	NULL
preinitiation	NULL
complex	NULL
formation	NULL
is	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
DNA-TFIID-TFIIA	NULL
complex	NULL
(	NULL
10	NULL
)	NULL
.	NULL

VP16	NULL
and	NULL
the	NULL
Epstein-Barr	NULL
virus	NULL
transactivator	NULL
Zta	NULL
,	NULL
which	NULL
both	NULL
interact	NULL
with	NULL
TFIIA	NULL
in	NULL
an	NULL
activation	NULL
domain-dependent	NULL
manner	NULL
(	NULL
49	NULL
,	NULL
67	NULL
)	NULL
,	NULL
increase	NULL
the	NULL
stability	NULL
and	NULL
rate	NULL
of	NULL
formation	NULL
of	NULL
DNA-TFIID-TFIIA	NULL
complexes	NULL
(	NULL
49	NULL
,	NULL
53	NULL
,	NULL
67	NULL
)	NULL
.	NULL

Another	NULL
recent	NULL
study	NULL
found	NULL
that	NULL
a	NULL
GAL4-VP16	NULL
fusion	NULL
protein	NULL
stimulated	NULL
the	NULL
formation	NULL
of	NULL
an	NULL
activated	NULL
transcription	NULL
complex	NULL
,	NULL
requiring	NULL
the	NULL
presence	NULL
of	NULL
TFIIA	NULL
,	NULL
the	NULL
TFIID	NULL
TAFs	NULL
,	NULL
and	NULL
the	NULL
nonhistone	NULL
chromosomal	NULL
protein	NULL
HMG-2	NULL
,	NULL
a	NULL
protein	NULL
that	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
role	NULL
in	NULL
the	NULL
architecture	NULL
of	NULL
the	NULL
transcription	NULL
complex	NULL
(	NULL
82	NULL
)	NULL
.	NULL

Purified	NULL
human	NULL
TFIIA	NULL
is	NULL
composed	NULL
of	NULL
stoichiometric	NULL
amounts	NULL
of	NULL
a	NULL
35-kDa	NULL
(	NULL
«	NULL
)	NULL
subunit	NULL
and	NULL
a	NULL
19-kDa	NULL
(	NULL
B	NULL
)	NULL
subunit	NULL
,	NULL
generated	NULL
from	NULL
a	NULL
55-kDa	NULL
precursor	NULL
(	NULL
aB	NULL
)	NULL
,	NULL
and	NULL
a	NULL
12-kDa	NULL
subunit	NULL
(	NULL
y	NULL
)	NULL
,	NULL
all	NULL
of	NULL
which	NULL
are	NULL
essential	NULL
for	NULL
TFIIA	NULL
function	NULL
(	NULL
16	NULL
,	NULL
17	NULL
,	NULL
55	NULL
,	NULL
67	NULL
,	NULL
87	NULL
,	NULL
106	NULL
,	NULL
107	NULL
)	NULL
.	NULL

The	NULL
cDNAs	NULL
encoding	NULL
the	NULL
highly	NULL
homologous	NULL
human	NULL
,	NULL
Drosophila	NULL
,	NULL
and	NULL
yeast	NULL
TFIIA	NULL
subunits	NULL
have	NULL
been	NULL
cloned	NULL
(	NULL
16	NULL
,	NULL
17	NULL
,	NULL
45	NULL
,	NULL
55	NULL
,	NULL
67	NULL
,	NULL
87	NULL
,	NULL
106	NULL
,	NULL
107	NULL
)	NULL
.	NULL

To	NULL
understand	NULL
the	NULL
molecular	NULL
mechanisms	NULL
by	NULL
which	NULL
Tax	NULL
regulates	NULL
transcription	NULL
from	NULL
RNA	NULL
polymerase	NULL
II	NULL
promoters	NULL
,	NULL
we	NULL
have	NULL
studied	NULL
the	NULL
potential	NULL
interaction	NULL
of	NULL
Tax	NULL
with	NULL
the	NULL
basal	NULL
transcription	NULL
factor	NULL
TFIIA	NULL
.	NULL

By	NULL
using	NULL
several	NULL
independent	NULL
assays	NULL
,	NULL
including	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
system	NULL
,	NULL
affinity	NULL
chromatog-raphy	NULL
,	NULL
and	NULL
coimmunoprecipitation	NULL
analysis	NULL
,	NULL
our	NULL
studies	NULL
have	NULL
shown	NULL
that	NULL
the	NULL
HTLV-1	NULL
transactivator	NULL
,	NULL
Tax	NULL
,	NULL
interacts	NULL
with	NULL
the	NULL
35-kDa	NULL
(	NULL
«	NULL
)	NULL
subunit	NULL
of	NULL
TFIIA	NULL
.	NULL

Importantly	NULL
,	NULL
two	NULL
Tax	NULL
mutants	NULL
which	NULL
fail	NULL
to	NULL
activate	NULL
transcription	NULL
in	NULL
vivo	NULL
failed	NULL
to	NULL
interact	NULL
with	NULL
TFIIA	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
demonstrate	NULL
that	NULL
TFIIA	NULL
is	NULL
important	NULL
for	NULL
Tax	NULL
transactivation	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
assays	NULL
with	NULL
cell	NULL
extracts	NULL
depleted	NULL
of	NULL
TFIIA	NULL
showed	NULL
a	NULL
marked	NULL
reduction	NULL
in	NULL
Tax-activated	NULL
transcription	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
Tax-mediated	NULL
transactivation	NULL
was	NULL
enhanced	NULL
in	NULL
human	NULL
T	NULL
lymphocytes	NULL
upon	NULL
coexpression	NULL
of	NULL
holo-TFIIA	NULL
.	NULL

Our	NULL
studies	NULL
suggest	NULL
that	NULL
one	NULL
mechanism	NULL
of	NULL
Tax	NULL
transactivation	NULL
involves	NULL
contact	NULL
with	NULL
the	NULL
transcriptional	NULL
machinery	NULL
through	NULL
TFIIA	NULL
,	NULL
thereby	NULL
altering	NULL
the	NULL
level	NULL
of	NULL
transcription	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Two-hybrid	NULL
interaction	NULL
assay	NULL
.	NULL

The	NULL
LexA	NULL
DNA-binding	NULL
domain	NULL
(	NULL
DBD	NULL
)	NULL
fusion	NULL
proteins	NULL
were	NULL
generated	NULL
with	NULL
the	NULL
2m	NULL
HIS3	NULL
yeast	NULL
shuttle	NULL
vector	NULL
,	NULL
pNL202	NULL
,	NULL
which	NULL
is	NULL
identical	NULL
to	NULL
pBEG202	NULL
(	NULL
31	NULL
)	NULL
with	NULL
the	NULL
addition	NULL
of	NULL
a	NULL
simian	NULL
virus	NULL
40	NULL
nuclear	NULL
localization	NULL
signal	NULL
,	NULL
consisting	NULL
of	NULL
amino	NULL
acids	NULL
PPKKKRKVA	NULL
,	NULL
inserted	NULL
downstream	NULL
of	NULL
the	NULL
202-amino-acid	NULL
LexA	NULL
moiety	NULL
.	NULL

The	NULL
activation	NULL
domain	NULL
(	NULL
AD	NULL
)	NULL
fusion	NULL
proteins	NULL
were	NULL
generated	NULL
with	NULL
the	NULL
2um	NULL
TRPZ	NULL
yeast	NULL
shuttle	NULL
vector	NULL
,	NULL
pJG4-5	NULL
,	NULL
which	NULL
directs	NULL
the	NULL
synthesis	NULL
of	NULL
the	NULL
simian	NULL
virus	NULL
40	NULL
nuclear	NULL
localization	NULL
signal	NULL
(	NULL
as	NULL
in	NULL
pNL202	NULL
)	NULL
,	NULL
the	NULL
B42	NULL
acidic	NULL
activation	NULL
domain	NULL
,	NULL
and	NULL
the	NULL
influenza	NULL
virus	NULL
HA1	NULL
epitope	NULL
tag	NULL
(	NULL
total	NULL
of	NULL
107	NULL
amino	NULL
acids	NULL
)	NULL
(	NULL
31	NULL
)	NULL
.	NULL

The	NULL
LexA	NULL
DBD	NULL
fusion	NULL
proteins	NULL
are	NULL
constitutively	NULL
expressed	NULL
from	NULL
the	NULL
ADF	NULL
promoter	NULL
,	NULL
while	NULL
the	NULL
AD	NULL
fusion	NULL
proteins	NULL
are	NULL
expressed	NULL
from	NULL
the	NULL
galactose-induced	NULL
,	NULL
glucose-repressed	NULL
GeZ-Z	NULL
promoter	NULL
.	NULL

The	NULL
2m	NULL
URA3	NULL
reporter	NULL
plasmid	NULL
,	NULL
pJK103	NULL
,	NULL
directs	NULL
the	NULL
synthesis	NULL
of	NULL
the	NULL
lacZ	NULL
gene	NULL
from	NULL
HTLV-1	NULL
Tax	NULL
TRANSACTIVATOR	NULL
INTERACTION	NULL
WITH	NULL
TFIIA	NULL
4657	NULL
a	NULL
minimal	NULL
GeZZ	NULL
promoter	NULL
controlled	NULL
by	NULL
two	NULL
high-affinity	NULL
lexA	NULL
operator	NULL
sites	NULL
(	NULL
31	NULL
)	NULL
which	NULL
is	NULL
transcriptionally	NULL
silent	NULL
unless	NULL
bound	NULL
by	NULL
a	NULL
LexA-containing	NULL
protein	NULL
or	NULL
protein	NULL
complex	NULL
with	NULL
activation	NULL
potential	NULL
.	NULL

Cloning	NULL
of	NULL
the	NULL
fusion	NULL
protein	NULL
constructs	NULL
was	NULL
conducted	NULL
by	NULL
PCR	NULL
amplification	NULL
of	NULL
Tax	NULL
,	NULL
TFIIA	NULL
,	NULL
and	NULL
TBP	NULL
cDNAs	NULL
with	NULL
the	NULL
high-fidelity	NULL
polymerase	NULL
Vent	NULL
(	NULL
New	NULL
England	NULL
Biolabs	NULL
)	NULL
and	NULL
primers	NULL
with	NULL
the	NULL
appropriate	NULL
restriction	NULL
sites	NULL
designed	NULL
to	NULL
omit	NULL
the	NULL
initiating	NULL
methionine	NULL
.	NULL

Three	NULL
independent	NULL
clones	NULL
of	NULL
the	NULL
Tax-DBD	NULL
fusion	NULL
construct	NULL
(	NULL
and	NULL
mutants	NULL
)	NULL
were	NULL
tested	NULL
with	NULL
at	NULL
least	NULL
two	NULL
independent	NULL
clones	NULL
of	NULL
the	NULL
p55	NULL
and	NULL
p35	NULL
TFIIA-AD	NULL
fusion	NULL
constructs	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
the	NULL
Tax	NULL
mutants	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
of	NULL
Warner	NULL
Greene	NULL
,	NULL
University	NULL
of	NULL
California	NULL
,	NULL
San	NULL
Francisco	NULL
)	NULL
was	NULL
verified	NULL
by	NULL
sequence	NULL
analysis	NULL
(	NULL
Sequenase	NULL
;	NULL
U.S.	NULL
Biochemicals	NULL
)	NULL
.	NULL

Yeast	NULL
transformations	NULL
were	NULL
performed	NULL
by	NULL
the	NULL
standard	NULL
lithium	NULL
acetate	NULL
method	NULL
as	NULL
described	NULL
by	NULL
Gictz	NULL
et	NULL
al	NULL
.	NULL

(	NULL
29	NULL
)	NULL
with	NULL
Seccharomyces	NULL
cerevisiae	NULL
EGY188	NULL
(	NULL
MATa	NULL
trpl	NULL
ura3	NULL
his3	NULL
LEU	NULL
:	NULL
:	NULL
pLexop2-LEU2	NULL
)	NULL
previously	NULL
transformed	NULL
with	NULL
pJK103	NULL
(	NULL
31	NULL
)	NULL
.	NULL

pEG202	NULL
,	NULL
pJG4-5	NULL
,	NULL
pJK103	NULL
,	NULL
5.	NULL
cerevisiae	NULL
EGY188	NULL
,	NULL
and	NULL
anti-LexA	NULL
antibody	NULL
were	NULL
generously	NULL
provided	NULL
by	NULL
Roger	NULL
Brent	NULL
,	NULL
Massachusetts	NULL
General	NULL
Hospital	NULL
,	NULL
Boston	NULL
.	NULL

Levels	NULL
of	NULL
B-galactosidase	NULL
generated	NULL
from	NULL
the	NULL
pJK103	NULL
reporter	NULL
plasmid	NULL
were	NULL
used	NULL
as	NULL
a	NULL
measure	NULL
of	NULL
the	NULL
interaction	NULL
between	NULL
the	NULL
AD	NULL
and	NULL
DBD	NULL
fusion	NULL
proteins	NULL
.	NULL

B-Galactosidase	NULL
activity	NULL
was	NULL
determined	NULL
with	NULL
exponentially	NULL
growing	NULL
yeast	NULL
cells	NULL
12	NULL
to	NULL
14	NULL
h	NULL
after	NULL
induction	NULL
with	NULL
2.0	NULL
%	NULL
galactose	NULL
as	NULL
described	NULL
by	NULL
Reynolds	NULL
and	NULL
Lundblad	NULL
(	NULL
74	NULL
)	NULL
and	NULL
was	NULL
calculated	NULL
as	NULL
follows	NULL
:	NULL
1,000	NULL
(	NULL
OD	NULL
,	NULL
;	NULL
,	NULL
)	NULL
/	NULL
(	NULL
time	NULL
[	NULL
in	NULL
minutes	NULL
]	NULL
it	NULL
takes	NULL
for	NULL
substrate	NULL
to	NULL
turn	NULL
yellow	NULL
)	NULL
(	NULL
volume	NULL
[	NULL
in	NULL
milliliters	NULL
]	NULL
of	NULL
cell	NULL
suspen-sion	NULL
)	NULL
(	NULL
ODeng	NULL
)	NULL
.	NULL

GST-fusion	NULL
protein-binding	NULL
assays	NULL
.	NULL

Bacterially	NULL
generated	NULL
glutathione-	NULL
$	NULL
-trans-ferase	NULL
(	NULL
GST	NULL
)	NULL
-Tax	NULL
,	NULL
GST-Tax	NULL
M32	NULL
,	NULL
GST-TBP	NULL
,	NULL
and	NULL
GST	NULL
fusion	NULL
proteins	NULL
were	NULL
purified	NULL
by	NULL
binding	NULL
to	NULL
glutathione-Sepharose	NULL
beads	NULL
(	NULL
Pharmacia	NULL
)	NULL
and	NULL
quantitated	NULL
by	NULL
sodium	NULL
dodecyl	NULL
sulfate	NULL
(	NULL
SDS	NULL
)	NULL
-polyacrylamide	NULL
gel	NULL
electrophoresis	NULL
followed	NULL
by	NULL
Coomassic	NULL
blue	NULL
staining	NULL
.	NULL

A	NULL
100-ug	NULL
sample	NULL
of	NULL
the	NULL
GST-fusion	NULL
protein-bead	NULL
complex	NULL
was	NULL
incubated	NULL
with	NULL
1.5	NULL
mg	NULL
of	NULL
HeLa	NULL
whole-cell	NULL
extract	NULL
(	NULL
WCE	NULL
)	NULL
(	NULL
57	NULL
)	NULL
for	NULL
2	NULL
h	NULL
at	NULL
4°C	NULL
in	NULL
buffer	NULL
A	NULL
(	NULL
80	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
20	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
)	NULL
.	NULL

After	NULL
a	NULL
brief	NULL
centrifugation	NULL
,	NULL
the	NULL
supernatant	NULL
(	NULL
flowthrough	NULL
)	NULL
was	NULL
collected	NULL
and	NULL
the	NULL
protein-complexed	NULL
beads	NULL
were	NULL
washed	NULL
extensively	NULL
with	NULL
buffer	NULL
B	NULL
(	NULL
80	NULL
mM	NULL
KC	NULL
]	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
0.25	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
20	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
)	NULL
and	NULL
then	NULL
washed	NULL
with	NULL
400	NULL
pl	NULL
of	NULL
buffer	NULL
C	NULL
(	NULL
300	NULL
mM	NULL
KCl	NULL
,	NULL
1	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
20	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
)	NULL
.	NULL

Cellular	NULL
proteins	NULL
which	NULL
bound	NULL
to	NULL
the	NULL
fusion	NULL
protein-complexed	NULL
beads	NULL
were	NULL
eluted	NULL
with	NULL
buffer	NULL
D	NULL
(	NULL
2.0	NULL
M	NULL
NaCl	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
20	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.9	NULL
]	NULL
)	NULL
.	NULL

The	NULL
flowthrough	NULL
and	NULL
wash	NULL
fractions	NULL
were	NULL
precipitated	NULL
with	NULL
trichloroacetic	NULL
acid	NULL
.	NULL

A	NULL
100-pg	NULL
sample	NULL
of	NULL
HeLa	NULL
cell	NULL
extract	NULL
,	NULL
1/15	NULL
of	NULL
the	NULL
total	NULL
flowthrough	NULL
,	NULL
and	NULL
the	NULL
complete	NULL
wash	NULL
and	NULL
elution	NULL
fractions	NULL
were	NULL
run	NULL
on	NULL
an	NULL
SDS-4	NULL
to	NULL
20	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Western	NULL
blot	NULL
(	NULL
immunoblot	NULL
)	NULL
analysis	NULL
was	NULL
conducted	NULL
with	NULL
a	NULL
1:2,000	NULL
dilution	NULL
of	NULL
polyclonal	NULL
antiserum	NULL
to	NULL
the	NULL
35-kDa	NULL
subunit	NULL
of	NULL
TFIIA	NULL
(	NULL
UBI	NULL
)	NULL
.	NULL

The	NULL
blots	NULL
were	NULL
stripped	NULL
in	NULL
buffer	NULL
S	NULL
(	NULL
67.5	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
6.8	NULL
]	NULL
,	NULL
2	NULL
%	NULL
SDS	NULL
,	NULL
100	NULL
mM	NULL
B-mercaptocthanol	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
50°C	NULL
and	NULL
then	NULL
reblotted	NULL
with	NULL
a	NULL
1:1,000	NULL
dilution	NULL
of	NULL
antiserum	NULL
to	NULL
TFIIB	NULL
(	NULL
anti-TFIIB	NULL
,	NULL
C	NULL
;	NULL
§	NULL
;	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
,	NULL
Inc.	NULL
)	NULL
.	NULL

TFIIA	NULL
and	NULL
TFIIB	NULL
were	NULL
visualized	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
see	NULL
the	NULL
section	NULL
on	NULL
immunoblot	NULL
analysis	NULL
,	NULL
below	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
and	NULL
immunoblot	NULL
analysis	NULL
.	NULL

HTLV-1-infected	NULL
C81	NULL
human	NULL
T	NULL
lymphocytes	NULL
,	NULL
which	NULL
express	NULL
high	NULL
levels	NULL
of	NULL
Tax	NULL
,	NULL
were	NULL
lysed	NULL
in	NULL
TNN	NULL
buffer	NULL
(	NULL
50	NULL
mM	NULL
Tris-HCl	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
120	NULL
mM	NULL
NaCl	NULL
,	NULL
5	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
%	NULL
P-40	NULL
,	NULL
50	NULL
mM	NULL
NaF	NULL
,	NULL
0.2	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
100	NULL
pg	NULL
of	NULL
phenylmethyl-sulfonyl	NULL
fluoride	NULL
,	NULL
20	NULL
ug	NULL
of	NULL
aprotinin	NULL
per	NULL
ml	NULL
,	NULL
10	NULL
pg	NULL
of	NULL
leupeptin	NULL
per	NULL
ml	NULL
)	NULL
for	NULL
20	NULL
min	NULL
on	NULL
ice	NULL
,	NULL
and	NULL
then	NULL
cell	NULL
debris	NULL
was	NULL
removed	NULL
by	NULL
centrifugation	NULL
at	NULL
10,000	NULL
x	NULL
g	NULL
for	NULL
10	NULL
min	NULL
(	NULL
30	NULL
)	NULL
.	NULL

Immunoprecipitations	NULL
were	NULL
conducted	NULL
by	NULL
incubating	NULL
300	NULL
ug	NULL
of	NULL
total-cell	NULL
protein	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
with	NULL
3	NULL
pl	NULL
of	NULL
preimmune	NULL
rabbit	NULL
serum	NULL
,	NULL
rabbit	NULL
antibody	NULL
directed	NULL
against	NULL
the	NULL
35-kDa	NULL
(	NULL
«	NULL
)	NULL
subunit	NULL
of	NULL
TFIIA	NULL
(	NULL
Oncogene	NULL
Sciences	NULL
)	NULL
,	NULL
rabbit	NULL
antibody	NULL
directed	NULL
against	NULL
the	NULL
55-kDa	NULL
(	NULL
«	NULL
B	NULL
)	NULL
TFIIA	NULL
subunit	NULL
,	NULL
a	NULL
mixture	NULL
of	NULL
four	NULL
anti-Tax	NULL
monoclonal	NULL
antibodies	NULL
with	NULL
different	NULL
specificities	NULL
,	NULL
or	NULL
a	NULL
monoclonal	NULL
antibody	NULL
to	NULL
the	NULL
influenza	NULL
virus	NULL
HA1	NULL
epitope	NULL
(	NULL
12CA5	NULL
)	NULL
as	NULL
a	NULL
control	NULL
.	NULL

Selected	NULL
samples	NULL
were	NULL
precleared	NULL
with	NULL
40	NULL
pl	NULL
of	NULL
nonspecific	NULL
rabbit	NULL
antiserum	NULL
prior	NULL
to	NULL
treatment	NULL
with	NULL
immune	NULL
serum	NULL
.	NULL

Antibody-bound	NULL
proteins	NULL
were	NULL
collected	NULL
with	NULL
25	NULL
pl	NULL
of	NULL
a	NULL
0.1-g/ml	NULL
protein	NULL
A-Sepharose	NULL
(	NULL
Pharmacia	NULL
)	NULL
solution	NULL
in	NULL
TNN	NULL
buffer	NULL
.	NULL

Bound	NULL
proteins	NULL
were	NULL
washed	NULL
four	NULL
times	NULL
in	NULL
500	NULL
l	NULL
of	NULL
TNN	NULL
buffer	NULL
,	NULL
eluted	NULL
by	NULL
boiling	NULL
in	NULL
Laemmli	NULL
buffer	NULL
,	NULL
and	NULL
separated	NULL
on	NULL
an	NULL
SDS-10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

The	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
Immobilon-P	NULL
membranes	NULL
(	NULL
Millipore	NULL
)	NULL
at	NULL
100	NULL
V	NULL
for	NULL
1	NULL
h	NULL
at	NULL
4°C	NULL
with	NULL
Western	NULL
transfer	NULL
buffer	NULL
(	NULL
0.1	NULL
M	NULL
glycine	NULL
,	NULL
12.5	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
8.3	NULL
]	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
blocked	NULL
with	NULL
5	NULL
%	NULL
milk	NULL
powder	NULL
in	NULL
TNET	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris	NULL
[	NULL
pH	NULL
7.5	NULL
]	NULL
,	NULL
2.5	NULL
mM	NULL
EDTA	NULL
,	NULL
50	NULL
mM	NULL
NaCl	NULL
,	NULL
0.1	NULL
%	NULL
Tween	NULL
20	NULL
)	NULL
for	NULL
1	NULL
h	NULL
,	NULL
washed	NULL
in	NULL
TNET	NULL
without	NULL
milk	NULL
,	NULL
and	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
in	NULL
primary	NULL
antibody	NULL
(	NULL
1:1,000	NULL
dilution	NULL
of	NULL
Tax	NULL
monoclonal	NULL
antibody	NULL
mix	NULL
or	NULL
1:2,500	NULL
dilution	NULL
of	NULL
antibody	NULL
to	NULL
the	NULL
55-kDa	NULL
[	NULL
aB	NULL
]	NULL
subunit	NULL
of	NULL
TFIIA	NULL
)	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

After	NULL
extensive	NULL
washing	NULL
,	NULL
the	NULL
immunoprecipitated	NULL
proteins	NULL
were	NULL
detected	NULL
with	NULL
the	NULL
appropriate	NULL
horseradish	NULL
peroxidase-linked	NULL
secondary	NULL
antibody	NULL
followed	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
(	NULL
Amersham	NULL
}	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
assay	NULL
.	NULL

Assays	NULL
were	NULL
conducted	NULL
with	NULL
the	NULL
pTRE-1	NULL
;	NULL
,	NULL
plasmid	NULL
containing	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
promoter-proximal	NULL
21-bp	NULL
repeat	NULL
from	NULL
the	NULL
HTLV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
upstream	NULL
of	NULL
the	NULL
chicken	NULL
ovalbumin	NULL
TATA	NULL
box	NULL
and	NULL
a	NULL
G-free	NULL
cassette	NULL
as	NULL
described	NULL
by	NULL
Duvall	NULL
et	NULL
al	NULL
.	NULL

(	NULL
19	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
analyzed	NULL
on	NULL
a	NULL
4	NULL
%	NULL
denaturing	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

HeLa	NULL
whole-cell	NULL
extracts	NULL
were	NULL
depleted	NULL
of	NULL
TFIIA	NULL
by	NULL
incubation	NULL
with	NULL
protein	NULL
A-Sepharose-coupled	NULL
(	NULL
Pharmacia	NULL
)	NULL
preimmune	NULL
or	NULL
immune	NULL
serum	NULL
specific	NULL
for	NULL
the	NULL
55-kDa	NULL
(	NULL
«	NULL
B	NULL
)	NULL
subunit	NULL
of	NULL
TFIIA	NULL
(	NULL
19	NULL
)	NULL
.	NULL

The	NULL
depleted	NULL
extracts	NULL
and	NULL
bound	NULL
proteins	NULL
were	NULL
analyzed	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
TFIIA	NULL
and	NULL
TBP	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
as	NULL
described	NULL
by	NULL
Duvall	NULL
et	NULL
al	NULL
.	NULL

(	NULL
19	NULL
)	NULL
.	NULL

4658	NULL
CLEMENS	NULL
ET	NULL
AL	NULL
.	NULL

Transfection	NULL
and	NULL
CAT	NULL
assays	NULL
.	NULL

The	NULL
cDNA	NULL
encoding	NULL
the	NULL
55-kDa	NULL
precursor	NULL
(	NULL
aB	NULL
)	NULL
of	NULL
TFIIA	NULL
(	NULL
pCMV55	NULL
)	NULL
was	NULL
cloned	NULL
as	NULL
a	NULL
HindIII-NofI	NULL
fragment	NULL
and	NULL
the	NULL
cDNA	NULL
encoding	NULL
12	NULL
kDa	NULL
(	NULL
y	NULL
)	NULL
of	NULL
TFIIA	NULL
(	NULL
pCMV12	NULL
)	NULL
was	NULL
cloned	NULL
as	NULL
a	NULL
HindII-BamHI	NULL
fragment	NULL
into	NULL
the	NULL
peDNA3	NULL
vector	NULL
(	NULL
InVitrogen	NULL
)	NULL
,	NULL
which	NULL
directs	NULL
transcription	NULL
from	NULL
the	NULL
cytomegalovirus	NULL
promoter	NULL
.	NULL

The	NULL
cDNA	NULL
for	NULL
HTLV-1	NULL
Tax	NULL
was	NULL
expressed	NULL
from	NULL
the	NULL
cytomegalovirus	NULL
promoter	NULL
by	NULL
using	NULL
the	NULL
pCTax	NULL
construct	NULL
(	NULL
84	NULL
)	NULL
.	NULL

pU3RCAT	NULL
contains	NULL
the	NULL
upstream	NULL
HTLV-1	NULL
long	NULL
terminal	NULL
repeat	NULL
(	NULL
LTR	NULL
)	NULL
driving	NULL
the	NULL
chloramphenicol	NULL
acetyltransferase	NULL
reporter	NULL
gene	NULL
(	NULL
47	NULL
)	NULL
.	NULL

Human	NULL
Jurkat	NULL
T	NULL
lymphocytes	NULL
(	NULL
78	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
(	NULL
Gibco/BRL	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
.	NULL

Cells	NULL
(	NULL
1.5	NULL
x	NULL
10	NULL
``	NULL
)	NULL
were	NULL
electroporated	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
47	NULL
)	NULL
with	NULL
0	NULL
to	NULL
10	NULL
ng	NULL
of	NULL
pCTax	NULL
,	NULL
0	NULL
to	NULL
50	NULL
ng	NULL
of	NULL
pCMVp55	NULL
(	NULL
«	NULL
B	NULL
)	NULL
,	NULL
0	NULL
to	NULL
200	NULL
ng	NULL
of	NULL
pCMVp12	NULL
(	NULL
7	NULL
)	NULL
,	NULL
and	NULL
1	NULL
pg	NULL
of	NULL
pU3RCAT	NULL
.	NULL

Chloramphenicol	NULL
acetyltransferase	NULL
activity	NULL
was	NULL
assayed	NULL
16	NULL
h	NULL
posttransfection	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
40	NULL
)	NULL
.	NULL

Results	NULL
were	NULL
quantitated	NULL
with	NULL
a	NULL
PhosphorImager	NULL
and	NULL
the	NULL
Image	NULL
Quant	NULL
program	NULL
(	NULL
Molecular	NULL
Dynamics	NULL
)	NULL
.	NULL

RESULTS	NULL
Tax	NULL
associates	NULL
with	NULL
TFIIA	NULL
in	NULL
S.	NULL
cerevisige	NULL
.	NULL

The	NULL
interaction	NULL
between	NULL
Tax	NULL
and	NULL
TFIIA	NULL
was	NULL
first	NULL
analyzed	NULL
in	NULL
vivo	NULL
with	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
interaction	NULL
system	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Wild-type	NULL
Tax	NULL
and	NULL
several	NULL
previously	NULL
characterized	NULL
Tax	NULL
point	NULL
mutants	NULL
(	NULL
84	NULL
)	NULL
were	NULL
generated	NULL
as	NULL
fusion	NULL
proteins	NULL
with	NULL
the	NULL
DBD	NULL
of	NULL
LexA	NULL
by	NULL
in-frame	NULL
cloning	NULL
into	NULL
the	NULL
yeast	NULL
shuttle	NULL
vector	NULL
,	NULL
pNL202	NULL
.	NULL

The	NULL
55-kDa	NULL
precursor	NULL
(	NULL
«	NULL
B	NULL
)	NULL
,	NULL
and	NULL
the	NULL
35-	NULL
,	NULL
19-	NULL
,	NULL
and	NULL
12-kDa	NULL
(	NULL
«	NULL
,	NULL
B	NULL
,	NULL
and	NULL
y	NULL
,	NULL
respectively	NULL
)	NULL
subunits	NULL
of	NULL
TFIIA	NULL
were	NULL
expressed	NULL
as	NULL
fusion	NULL
proteins	NULL
with	NULL
the	NULL
epitope-tagged	NULL
(	NULL
HA1	NULL
)	NULL
acidic	NULL
AD	NULL
by	NULL
using	NULL
the	NULL
pJG4-5	NULL
shuttle	NULL
vector	NULL
.	NULL

Interaction	NULL
between	NULL
the	NULL
protein	NULL
fused	NULL
to	NULL
the	NULL
LexA	NULL
DBD	NULL
and	NULL
the	NULL
protein	NULL
fused	NULL
to	NULL
the	NULL
acidic	NULL
AD	NULL
results	NULL
in	NULL
the	NULL
localization	NULL
of	NULL
the	NULL
AD	NULL
to	NULL
the	NULL
LexA	NULL
operator	NULL
on	NULL
the	NULL
pJK103	NULL
reporter	NULL
plasmid	NULL
and	NULL
subsequent	NULL
activation	NULL
of	NULL
the	NULL
lacZ	NULL
gene	NULL
.	NULL

The	NULL
Tax	NULL
DBD	NULL
,	NULL
which	NULL
possessed	NULL
a	NULL
low	NULL
intrinsic	NULL
level	NULL
of	NULL
activation	NULL
(	NULL
twofold	NULL
above	NULL
that	NULL
of	NULL
the	NULL
DBD	NULL
vector	NULL
alone	NULL
[	NULL
data	NULL
not	NULL
shown	NULL
]	NULL
)	NULL
,	NULL
showed	NULL
a	NULL
significant	NULL
level	NULL
of	NULL
interaction	NULL
with	NULL
the	NULL
35-kDa	NULL
(	NULL
«	NULL
)	NULL
subunit	NULL
of	NULL
TFIIA	NULL
(	NULL
p35-AD	NULL
)	NULL
(	NULL
11.4-fold	NULL
over	NULL
Tax	NULL
DBD	NULL
levels	NULL
)	NULL
and	NULL
with	NULL
the	NULL
55-kDa	NULL
(	NULL
«	NULL
B	NULL
)	NULL
precursor	NULL
protein	NULL
(	NULL
p55-AD	NULL
)	NULL
(	NULL
5.2-fold	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Both	NULL
wild-type	NULL
and	NULL
mutant	NULL
Tax	NULL
proteins	NULL
failed	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
19-kDa	NULL
(	NULL
B	NULL
)	NULL
or	NULL
12-kDa	NULL
(	NULL
y	NULL
)	NULL
TFIIA	NULL
subunits	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Tax	NULL
was	NULL
also	NULL
tested	NULL
for	NULL
interaction	NULL
with	NULL
the	NULL
general	NULL
transcription	NULL
factors	NULL
TBP	NULL
and	NULL
TFIIB	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Although	NULL
earlier	NULL
reports	NULL
suggest	NULL
an	NULL
association	NULL
between	NULL
Tax	NULL
and	NULL
TBP	NULL
in	NULL
vitro	NULL
(	NULL
8	NULL
)	NULL
,	NULL
the	NULL
interaction	NULL
between	NULL
these	NULL
two	NULL
proteins	NULL
in	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
system	NULL
was	NULL
negligi-ble	NULL
.	NULL

Similarly	NULL
,	NULL
no	NULL
interaction	NULL
was	NULL
observed	NULL
between	NULL
Tax	NULL
and	NULL
TFIIB	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
.	NULL

Additionally	NULL
,	NULL
when	NULL
TFIIA	NULL
was	NULL
tested	NULL
for	NULL
association	NULL
with	NULL
the	NULL
Drosophilia	NULL
transactivator	NULL
Bicoid	NULL
,	NULL
no	NULL
interaction	NULL
was	NULL
observed	NULL
,	NULL
implying	NULL
that	NULL
TFIIA	NULL
does	NULL
not	NULL
bind	NULL
to	NULL
transactivators	NULL
indiscriminately	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
a	NULL
further	NULL
control	NULL
for	NULL
these	NULL
studies	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
Tax	NULL
with	NULL
TFIIA	NULL
was	NULL
compared	NULL
with	NULL
the	NULL
interaction	NULL
of	NULL
TBP	NULL
and	NULL
TFIIA	NULL
,	NULL
which	NULL
have	NULL
been	NULL
shown	NULL
previously	NULL
to	NULL
interact	NULL
in	NULL
the	NULL
cell	NULL
.	NULL

In	NULL
both	NULL
vector	NULL
orientations	NULL
,	NULL
TBP	NULL
and	NULL
TFIIA	NULL
interaction	NULL
levels	NULL
were	NULL
approximately	NULL
twofold	NULL
higher	NULL
than	NULL
the	NULL
levels	NULL
of	NULL
interaction	NULL
between	NULL
Tax	NULL
and	NULL
TFIIA	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
the	NULL
TBP	NULL
,	NULL
TFIIB	NULL
,	NULL
Bicoid	NULL
,	NULL
and	NULL
TFIIA	NULL
fusion	NULL
proteins	NULL
were	NULL
confirmed	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Several	NULL
Tax	NULL
point	NULL
mutants	NULL
,	NULL
previously	NULL
tested	NULL
in	NULL
lymphocytes	NULL
for	NULL
transactivation	NULL
of	NULL
the	NULL
HTLV-1	NULL
LTR	NULL
,	NULL
via	NULL
the	NULL
CREB	NULL
activation	NULL
pathway	NULL
,	NULL
and	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HIV-1	NULL
)	NULL
LTR	NULL
,	NULL
via	NULL
the	NULL
NF-KB	NULL
activation	NULL
pathway	NULL
,	NULL
were	NULL
tested	NULL
for	NULL
interaction	NULL
with	NULL
TFIIA	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
(	NULL
84	NULL
)	NULL
.	NULL

We	NULL
chose	NULL
to	NULL
evaluate	NULL
a	NULL
subset	NULL
of	NULL
mutants	NULL
whose	NULL
previous	NULL
characterization	NULL
(	NULL
84	NULL
)	NULL
was	NULL
not	NULL
biased	NULL
as	NULL
a	NULL
result	NULL
of	NULL
abnormal	NULL
protein	NULL
localization	NULL
or	NULL
stability	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

The	NULL
M3	NULL
(	NULL
F13A	NULL
G148	NULL
)	NULL
,	NULL
M16	NULL
(	NULL
P92A	NULL
P93S	NULL
)	NULL
,	NULL
M19	NULL
(	NULL
Q126A	NULL
,	NULL
H1278	NULL
)	NULL
,	NULL
and	NULL
M45	NULL
(	NULL
I315R	NULL
,	NULL
P3168	NULL
)	NULL
mutants	NULL
were	NULL
shown	NULL
previously	NULL
to	NULL
transactivate	NULL
,	NULL
often	NULL
weakly	NULL
,	NULL
both	NULL
the	NULL
HTLV-1	NULL
and	NULL
HIV-1	NULL
LTR	NULL
promoters	NULL
The	NULL
M47	NULL
mutant	NULL
(	NULL
L319R	NULL
,	NULL
L320S	NULL
)	NULL
was	NULL
able	NULL
to	NULL
activate	NULL
only	NULL
the	NULL
HIV-1	NULL
LTR	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Fold	NULL
Induction	NULL
Fold	NULL
Induction	NULL
M47	NULL
(	NULL
cro-320	NULL
)	NULL
M21	NULL
M32	NULL
M45	NULL
(	NULL
134-138	NULL
)	NULL
(	NULL
19-197	NULL
)	NULL
pitsiq	NULL
M3	NULL
M16	NULL
-	NULL
M19	NULL
M30	NULL
M41	NULL
(	NULL
1344	NULL
)	NULL
(	NULL
@	NULL
ta2	NULL
.	NULL

(	NULL
rear	NULL
)	NULL
(	NULL
192-193	NULL
)	NULL
cerzsq	NULL
|	NULL
\	NULL
|__	NULL
]	NULL
|	NULL
|	NULL
1	NULL
50	NULL
100	NULL
150	NULL
200	NULL
250	NULL
300	NULL
353	NULL
amino	NULL
acids	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Tax	NULL
associates	NULL
with	NULL
TFIIA	NULL
in	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
interaction	NULL
system	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Levels	NULL
of	NULL
interaction	NULL
between	NULL
Tax	NULL
and	NULL
TFIIA	NULL
,	NULL
TBP	NULL
,	NULL
and	NULL
TFIIB	NULL
.	NULL

B-Galactosidase	NULL
levels	NULL
,	NULL
which	NULL
reflect	NULL
the	NULL
extent	NULL
of	NULL
interaction	NULL
between	NULL
the	NULL
chimeric	NULL
DBD	NULL
and	NULL
AD	NULL
fusion	NULL
proteins	NULL
,	NULL
are	NULL
displayed	NULL
as	NULL
the	NULL
fold	NULL
increase	NULL
over	NULL
levels	NULL
observed	NULL
with	NULL
each	NULL
chimeric	NULL
DBD	NULL
fusion	NULL
protein	NULL
and	NULL
the	NULL
AD	NULL
vector	NULL
alone	NULL
.	NULL

(	NULL
B	NULL
)	NULL
B-Galactosidase	NULL
levels	NULL
as	NULL
determined	NULL
in	NULL
panel	NULL
A	NULL
with	NULL
cells	NULL
constitutively	NULL
expressing	NULL
the	NULL
wild-type	NULL
or	NULL
M3	NULL
,	NULL
M16	NULL
,	NULL
M19	NULL
,	NULL
M21	NULL
,	NULL
M30	NULL
,	NULL
M32	NULL
,	NULL
M41	NULL
,	NULL
M45	NULL
,	NULL
or	NULL
M47	NULL
Tax-DBD	NULL
fusion	NULL
proteins	NULL
approximately	NULL
12	NULL
to	NULL
14	NULL
h	NULL
after	NULL
galactose	NULL
induction	NULL
of	NULL
the	NULL
TFILA-AD	NULL
fusion	NULL
protein	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
.	NULL

Results	NULL
are	NULL
the	NULL
mean	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Diagram	NULL
showing	NULL
amino	NULL
acid	NULL
modifications	NULL
of	NULL
the	NULL
Tax	NULL
mutants	NULL
used	NULL
in	NULL
this	NULL
study	NULL
(	NULL
84	NULL
)	NULL
.	NULL

Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
Bo	NULL
pp	NULL
$	NULL
8888	NULL
p	NULL
&	NULL
&	NULL
&	NULL
&	NULL
S8	NULL
RPN	NULL
\Q\Q\°	NULL
’	NULL
\°	NULL
‘	NULL
5	NULL
o	NULL
CRC	NULL
0	NULL
§	NULL
8	NULL
x	NULL
&	NULL
2	NULL
8	NULL
&	NULL
§	NULL
¢	NULL
¢	NULL
¢	NULL
m	NULL
S	NULL
S	NULL
S	NULL
S	NULL
S	NULL
S	NULL
R	NULL
S	NULL
5	NULL
S	NULL
$	NULL
G	NULL
85	NULL
6	NULL
6	NULL
0	NULL
Ww	NULL
©	NULL
§	NULL
$	NULL
8	NULL
»	NULL
n	NULL
@	NULL
5	NULL
©	NULL
$	NULL
&	NULL
a	NULL
S	NULL
r	NULL
¢ox	NULL
82	NULL
2	NULL
~	NULL
w	NULL
~	NULL
&	NULL
16	NULL
16	NULL
6	NULL
C	NULL
&	NULL
§	NULL
&	NULL
p	NULL
@	NULL
~	NULL
A	NULL
&	NULL
a	NULL
RS	NULL
S	NULL
ware	NULL
«	NULL
«	NULL
<	NULL
-	NULL
p55	NULL
S45	NULL
)	NULL
-	NULL
:	NULL
:	NULL
:	NULL
«	NULL
+	NULL
oss	NULL
tos	NULL
.	NULL

ie	NULL
Sowe	NULL
:	NULL
woe	NULL
<	NULL
-	NULL
p19	NULL
``	NULL
WR	NULL
<	NULL
-	NULL
p12	NULL
*	NULL
``	NULL
\	NULL
<	NULL
-	NULL
AD	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
of	NULL
cells	NULL
coexpressing	NULL
the	NULL
Tax-DBD	NULL
and	NULL
TFIIA-AD	NULL
fusion	NULL
proteins	NULL
.	NULL

(	NULL
A	NULL
and	NULL
B	NULL
)	NULL
Cells	NULL
coexpressing	NULL
both	NULL
fusion	NULL
proteins	NULL
were	NULL
lysed	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
,	NULL
and	NULL
150	NULL
pg	NULL
of	NULL
total-cell	NULL
protein	NULL
was	NULL
analyzed	NULL
on	NULL
an	NULL
SDS-10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Following	NULL
electrophoretic	NULL
separa-tion	NULL
,	NULL
the	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
Immobilon	NULL
and	NULL
immunoblotted	NULL
with	NULL
a	NULL
1:2,000	NULL
dilution	NULL
of	NULL
serum	NULL
directed	NULL
against	NULL
the	NULL
LexA	NULL
moiety	NULL
of	NULL
the	NULL
DBD-fusion	NULL
protein	NULL
(	NULL
provided	NULL
by	NULL
Roger	NULL
Brent	NULL
)	NULL
,	NULL
and	NULL
proteins	NULL
were	NULL
analyzed	NULL
by	NULL
enhanced	NULL
chemiluminescence	NULL
.	NULL

Lanes	NULL
are	NULL
identified	NULL
by	NULL
the	NULL
DBD/AD	NULL
fusion	NULL
proteins	NULL
that	NULL
are	NULL
coexpressed	NULL
in	NULL
each	NULL
sample	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Comparison	NULL
of	NULL
p55	NULL
TFIIA-AD	NULL
levels	NULL
in	NULL
cells	NULL
coexpressing	NULL
the	NULL
wild-type	NULL
,	NULL
M32	NULL
,	NULL
and	NULL
M41	NULL
Tax-DBD	NULL
fusion	NULL
proteins	NULL
.	NULL

Total-cell	NULL
protein	NULL
(	NULL
300	NULL
pg	NULL
)	NULL
was	NULL
immunoprecipitated	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
with	NULL
5	NULL
pg	NULL
of	NULL
antibody	NULL
directed	NULL
against	NULL
the	NULL
HA	NULL
epitope	NULL
(	NULL
12CA5	NULL
)	NULL
on	NULL
the	NULL
AD	NULL
fusion	NULL
protein	NULL
.	NULL

The	NULL
precipitated	NULL
material	NULL
was	NULL
run	NULL
on	NULL
an	NULL
SDS-10	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
transferred	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
the	NULL
HA	NULL
antisera	NULL
as	NULL
described	NULL
for	NULL
panel	NULL
B	NULL
.	NULL

(	NULL
D	NULL
)	NULL
Same	NULL
samples	NULL
as	NULL
in	NULL
panel	NULL
A	NULL
,	NULL
except	NULL
that	NULL
50	NULL
pg	NULL
of	NULL
total-cell	NULL
protein	NULL
was	NULL
separated	NULL
on	NULL
a	NULL
mini	NULL
SDS-4	NULL
to	NULL
20	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
transferred	NULL
to	NULL
a	NULL
polyvi-nylidene	NULL
difluoride	NULL
membrane	NULL
,	NULL
and	NULL
immunoblotted	NULL
with	NULL
a	NULL
1:4,000	NULL
dilution	NULL
of	NULL
antiserum	NULL
directed	NULL
against	NULL
the	NULL
HA	NULL
epitope	NULL
tag	NULL
on	NULL
the	NULL
AD	NULL
fusion	NULL
protein	NULL
(	NULL
12CA5	NULL
;	NULL
Berkeley	NULL
)	NULL
.	NULL

promoter	NULL
.	NULL

The	NULL
M21	NULL
(	NULL
P134	NULL
,	NULL
D135S	NULL
)	NULL
,	NULL
M30	NULL
(	NULL
D192A	NULL
,	NULL
G1938	NULL
)	NULL
,	NULL
M32	NULL
(	NULL
Y¥196A	NULL
,	NULL
K1978	NULL
)	NULL
,	NULL
and	NULL
M41	NULL
(	NULL
H287A	NULL
,	NULL
P288S	NULL
)	NULL
mutants	NULL
were	NULL
unable	NULL
to	NULL
activate	NULL
either	NULL
viral	NULL
LTR	NULL
(	NULL
84	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
transactivation-defective	NULL
Tax	NULL
mutants	NULL
,	NULL
M32	NULL
(	NULL
Y196A	NULL
,	NULL
K1978	NULL
)	NULL
and	NULL
M41	NULL
(	NULL
H287A	NULL
,	NULL
P288S	NULL
)	NULL
failed	NULL
to	NULL
interact	NULL
with	NULL
either	NULL
the	NULL
55-kDa	NULL
(	NULL
«	NULL
B	NULL
)	NULL
precursor	NULL
or	NULL
the	NULL
35-kDa	NULL
(	NULL
«	NULL
)	NULL
subunit	NULL
of	NULL
TFIIA	NULL
.	NULL

The	NULL
remaining	NULL
Tax	NULL
mutants	NULL
used	NULL
in	NULL
this	NULL
assay	NULL
were	NULL
able	NULL
to	NULL
interact	NULL
with	NULL
both	NULL
the	NULL
p55	NULL
and	NULL
p35	NULL
TFIIA	NULL
proteins	NULL
.	NULL

Western	NULL
blot	NULL
analysis	NULL
demonstrated	NULL
that	NULL
all	NULL
the	NULL
mutant	NULL
Tax	NULL
DBD	NULL
fusion	NULL
proteins	NULL
,	NULL
including	NULL
M32	NULL
and	NULL
M41	NULL
,	NULL
were	NULL
expressed	NULL
at	NULL
similar	NULL
levels	NULL
during	NULL
coexpression	NULL
of	NULL
the	NULL
TFIIA-AD	NULL
fusion	NULL
protein	NULL
,	NULL
demonstrating	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
interaction	NULL
is	NULL
not	NULL
due	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
fusion	NULL
protein	NULL
(	NULL
Fig	NULL
.	NULL

2A	NULL
and	NULL
B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
p55	NULL
,	NULL
p35	NULL
,	NULL
p19	NULL
,	NULL
and	NULL
p12	NULL
TFIIA	NULL
AD	NULL
fusion	NULL
proteins	NULL
were	NULL
all	NULL
expressed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
wild-type	NULL
Tax	NULL
DBD	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
inability	NULL
of	NULL
Tax	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
p19	NULL
and	NULL
p12	NULL
subunits	NULL
was	NULL
not	NULL
due	NULL
to	NULL
a	NULL
change	NULL
in	NULL
the	NULL
stability	NULL
or	NULL
expression	NULL
of	NULL
the	NULL
fusion	NULL
proteins	NULL
(	NULL
Fig	NULL
.	NULL

2C	NULL
and	NULL
D	NULL
)	NULL
.	NULL

TFIIA	NULL
from	NULL
HeLa	NULL
cells	NULL
interacts	NULL
with	NULL
GST-Tax	NULL
.	NULL

We	NULL
next	NULL
determined	NULL
if	NULL
native	NULL
TFIIA	NULL
could	NULL
interact	NULL
with	NULL
the	NULL
HTLV-1	NULL
Tax	NULL
protein	NULL
.	NULL

HeLa	NULL
WCE	NULL
was	NULL
incubated	NULL
with	NULL
purified	NULL
GST-Tax	NULL
,	NULL
GST-Tax	NULL
M32	NULL
,	NULL
GST-TBP	NULL
,	NULL
or	NULL
GST	NULL
protein	NULL
complexed	NULL
to	NULL
glutathione-Sepharose	NULL
beads	NULL
.	NULL

Following	NULL
a	NULL
2-h	NULL
incubation	NULL
,	NULL
the	NULL
su-	NULL
HTLV-1	NULL
Tax	NULL
TRANSACTIVATOR	NULL
INTERACTION	NULL
WITH	NULL
TFIIA	NULL
4659	NULL
A	NULL
B	NULL
TBP	NULL
Tax	NULL
ast	NULL
[	NULL
C-T	NULL
-T	NULL
Elution	NULL
©	NULL
©	NULL
©	NULL
u	NULL
.	NULL

&	NULL
§	NULL
.	NULL

5	NULL
S.	NULL
§§	NULL
&	NULL
o	NULL
&	NULL
&	NULL
&	NULL
an	NULL
Co	NULL
SF	NULL
g	NULL
6¢Y	NULL
4	NULL
6	NULL
¢	NULL
J	NULL
&	NULL
$	NULL
P	NULL
TFIIA	NULL
(	NULL
p35	NULL
)	NULL
-P|	NULL
«	NULL
»	NULL
@	NULL
-	NULL
-	NULL
--	NULL
l	NULL
o	NULL
|	NULL
TFE	NULL
(	NULL
33	NULL
)	NULL
-	NULL
Ci	NULL
-	NULL
-	NULL
-P	NULL
a	NULL
»	NULL
1	NULL
2	NULL
3	NULL
4	NULL
50	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
13	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

TFIIA	NULL
from	NULL
HeLa	NULL
cells	NULL
interacts	NULL
with	NULL
GST-Tax	NULL
.	NULL

GST-Tax	NULL
,	NULL
GST-Tax	NULL
M32	NULL
,	NULL
GST-TBP	NULL
,	NULL
or	NULL
GST	NULL
fusion	NULL
proteins	NULL
(	NULL
100	NULL
pg	NULL
)	NULL
bound	NULL
to	NULL
glutathione-Sepharose	NULL
beads	NULL
were	NULL
incubated	NULL
with	NULL
1.5	NULL
mg	NULL
of	NULL
HeLa	NULL
WCE	NULL
.	NULL

After	NULL
collection	NULL
of	NULL
the	NULL
supernatant	NULL
,	NULL
the	NULL
beads	NULL
were	NULL
washed	NULL
and	NULL
bound	NULL
proteins	NULL
were	NULL
eluted	NULL
with	NULL
buffer	NULL
containing	NULL
2.0	NULL
M	NULL
NaCl	NULL
.	NULL

Hela	NULL
WCE	NULL
(	NULL
100	NULL
pg	NULL
)	NULL
,	NULL
1/15	NULL
of	NULL
the	NULL
supernatant	NULL
(	NULL
flowthrough	NULL
[	NULL
FT	NULL
]	NULL
)	NULL
,	NULL
and	NULL
the	NULL
entire	NULL
wash	NULL
(	NULL
Wash	NULL
)	NULL
and	NULL
elution	NULL
(	NULL
Elution	NULL
)	NULL
fractions	NULL
were	NULL
run	NULL
on	NULL
an	NULL
SDS-4	NULL
to	NULL
20	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
,	NULL
and	NULL
the	NULL
proteins	NULL
were	NULL
transferred	NULL
to	NULL
nitrocellulose	NULL
and	NULL
immunoblotted	NULL
with	NULL
antibody	NULL
against	NULL
the	NULL
p35	NULL
subunit	NULL
of	NULL
TFIIA	NULL
.	NULL

The	NULL
blot	NULL
was	NULL
stripped	NULL
and	NULL
reprobed	NULL
with	NULL
antibody	NULL
to	NULL
TFIIB	NULL
(	NULL
results	NULL
shown	NULL
below	NULL
the	NULL
TFIIA	NULL
results	NULL
)	NULL
.	NULL

pernatant	NULL
was	NULL
collected	NULL
(	NULL
flowthrough	NULL
fraction	NULL
)	NULL
and	NULL
the	NULL
beads	NULL
were	NULL
extensively	NULL
washed	NULL
with	NULL
a	NULL
low-ionic-strength	NULL
buffer	NULL
(	NULL
buffer	NULL
B	NULL
[	NULL
containing	NULL
80	NULL
mM	NULL
KCl	NULL
and	NULL
150	NULL
mM	NULL
NaCl	NULL
]	NULL
)	NULL
and	NULL
then	NULL
washed	NULL
once	NULL
with	NULL
a	NULL
higher-strength	NULL
buffer	NULL
(	NULL
buffer	NULL
C	NULL
[	NULL
containing	NULL
300	NULL
mM	NULL
KCIJ	NULL
)	NULL
.	NULL

The	NULL
bound	NULL
proteins	NULL
were	NULL
then	NULL
eluted	NULL
from	NULL
the	NULL
beads	NULL
with	NULL
2.0	NULL
M	NULL
NaCl	NULL
(	NULL
buffer	NULL
D	NULL
)	NULL
.	NULL

Then	NULL
1/15	NULL
volume	NULL
of	NULL
the	NULL
flowthrough	NULL
fraction	NULL
and	NULL
the	NULL
entire	NULL
wash	NULL
and	NULL
elution	NULL
fractions	NULL
were	NULL
examined	NULL
by	NULL
Western	NULL
blot	NULL
analysis	NULL
for	NULL
the	NULL
35-kDa	NULL
(	NULL
«	NULL
)	NULL
subunit	NULL
of	NULL
TFIIA	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

TFIIA	NULL
bound	NULL
to	NULL
GST-Tax	NULL
but	NULL
failed	NULL
to	NULL
interact	NULL
with	NULL
GST	NULL
alone	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
7	NULL
and	NULL
10	NULL
)	NULL
.	NULL

The	NULL
GST	NULL
-Tax	NULL
M32	NULL
mutant	NULL
,	NULL
which	NULL
failed	NULL
to	NULL
interact	NULL
with	NULL
TFIIA	NULL
in	NULL
the	NULL
two-hybrid	NULL
interaction	NULL
assay	NULL
,	NULL
demonstrated	NULL
a	NULL
20-fold	NULL
reduction	NULL
in	NULL
TFIIA-binding	NULL
when	NULL
compared	NULL
with	NULL
wild	NULL
type	NULL
GST-Tax	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
11	NULL
and	NULL
12	NULL
)	NULL
.	NULL

As	NULL
observed	NULL
in	NULL
the	NULL
two-hybrid	NULL
assay	NULL
,	NULL
interaction	NULL
between	NULL
TBP	NULL
and	NULL
TFIIA	NULL
was	NULL
greater	NULL
than	NULL
interaction	NULL
between	NULL
Tax	NULL
and	NULL
TFIIA	NULL
.	NULL

However	NULL
,	NULL
in	NULL
the	NULL
affinity	NULL
column	NULL
,	NULL
the	NULL
difference	NULL
in	NULL
association	NULL
is	NULL
more	NULL
pronounced	NULL
(	NULL
TBP	NULL
bound	NULL
TFIIA	NULL
14-fold	NULL
more	NULL
than	NULL
Tax	NULL
did	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
7	NULL
)	NULL
.	NULL

As	NULL
a	NULL
control	NULL
for	NULL
these	NULL
studies	NULL
and	NULL
to	NULL
confirm	NULL
results	NULL
from	NULL
the	NULL
two-hybrid	NULL
assay	NULL
,	NULL
the	NULL
interaction	NULL
of	NULL
the	NULL
GST	NULL
fusion	NULL
proteins	NULL
with	NULL
TFIIB	NULL
was	NULL
assessed	NULL
by	NULL
stripping	NULL
the	NULL
original	NULL
Western	NULL
blot	NULL
and	NULL
reprobing	NULL
with	NULL
antibody	NULL
directed	NULL
against	NULL
TFIIB	NULL
(	NULL
33	NULL
kDa	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
the	NULL
results	NULL
of	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
assay	NULL
,	NULL
Tax	NULL
was	NULL
unable	NULL
to	NULL
interact	NULL
with	NULL
TFIIB	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
,	NULL
bottom	NULL
,	NULL
lane	NULL
7	NULL
)	NULL
.	NULL

The	NULL
GST-TBP	NULL
protein	NULL
did	NULL
interact	NULL
with	NULL
TFIIB	NULL
,	NULL
albeit	NULL
less	NULL
efficiently	NULL
than	NULL
it	NULL
interacted	NULL
with	NULL
TFIIA	NULL
.	NULL

Tax	NULL
coprecipitates	NULL
with	NULL
TFIIA	NULL
in	NULL
HTLV-1	NULL
infected	NULL
cells	NULL
.	NULL

We	NULL
then	NULL
determined	NULL
if	NULL
Tax	NULL
could	NULL
associate	NULL
with	NULL
native	NULL
TFIIA	NULL
by	NULL
coimmunoprecipitation	NULL
analysis	NULL
by	NULL
using	NULL
WCE	NULL
from	NULL
Tax-expressing	NULL
C81	NULL
T	NULL
lymphocytes	NULL
.	NULL

Proteins	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
a	NULL
polyclonal	NULL
antiserum	NULL
directed	NULL
against	NULL
the	NULL
35-kDa	NULL
(	NULL
«	NULL
)	NULL
subunit	NULL
of	NULL
TFIIA	NULL
(	NULL
anti-TFIIA	NULL
)	NULL
or	NULL
a	NULL
nonspecific	NULL
rabbit	NULL
serum	NULL
(	NULL
PT	NULL
)	NULL
,	NULL
and	NULL
this	NULL
was	NULL
followed	NULL
by	NULL
Western	NULL
analysis	NULL
of	NULL
the	NULL
precipitated	NULL
proteins	NULL
with	NULL
an	NULL
anti-Tax	NULL
antibody	NULL
.	NULL

Tax	NULL
precipitated	NULL
with	NULL
the	NULL
anti-TFIIA	NULL
but	NULL
not	NULL
with	NULL
the	NULL
nonspecific	NULL
rabbit	NULL
serum	NULL
(	NULL
Fig	NULL
.	NULL

4A	NULL
)	NULL
.	NULL

In	NULL
a	NULL
reciprocal	NULL
experiment	NULL
,	NULL
we	NULL
immunoprecipitated	NULL
proteins	NULL
from	NULL
the	NULL
C81	NULL
cell	NULL
extracts	NULL
with	NULL
anti-Tax	NULL
monoclonal	NULL
antibodies	NULL
and	NULL
subjected	NULL
then	NULL
to	NULL
immunoblotting	NULL
with	NULL
TFIIA-specific	NULL
antisera	NULL
.	NULL

The	NULL
35-kDa	NULL
(	NULL
«	NULL
)	NULL
subunit	NULL
of	NULL
TFIIA	NULL
was	NULL
immunoprecipitated	NULL
with	NULL
the	NULL
monoclonal	NULL
antibody	NULL
to	NULL
Tax	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lane	NULL
3	NULL
)	NULL
but	NULL
not	NULL
with	NULL
a	NULL
control	NULL
monoclonal	NULL
antibody	NULL
against	NULL
the	NULL
HA1	NULL
epitope	NULL
(	NULL
12CA5	NULL
)	NULL
or	NULL
with	NULL
beads	NULL
alone	NULL
(	NULL
protein	NULL
4660	NULL
CLEMENS	NULL
ET	NULL
AL	NULL
.	NULL

A	NULL
anti-Tax	NULL
IP	NULL
|	NULL
ooo	NULL
st	NULL
a	NULL
FZ	NULL
00	NULL
;	NULL
anti-	NULL
TFIIA	NULL
TFIIA	NULL
p35-	NULL
»	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Coimmunoprecipitation	NULL
assays	NULL
demonstrating	NULL
Tax-TFIIA	NULL
association	NULL
in	NULL
Tax-expressing	NULL
T	NULL
lymphocytes	NULL
(	NULL
C81	NULL
cells	NULL
)	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Exponentially	NULL
growing	NULL
C81	NULL
cells	NULL
were	NULL
lysed	NULL
,	NULL
and	NULL
300	NULL
pg	NULL
of	NULL
total-cell	NULL
protein	NULL
was	NULL
immunoprecipitated	NULL
(	NULL
IP	NULL
)	NULL
with	NULL
3	NULL
pl	NULL
of	NULL
polyclonal	NULL
antibody	NULL
directed	NULL
against	NULL
the	NULL
35-kDa	NULL
subunit	NULL
of	NULL
TFIIA	NULL
(	NULL
anti-TFIIA	NULL
)	NULL
,	NULL
or	NULL
nonspecific	NULL
polyclonal	NULL
control	NULL
antibody	NULL
(	NULL
PT	NULL
)	NULL
.	NULL

Precipitated	NULL
proteins	NULL
along	NULL
with	NULL
50	NULL
ug	NULL
of	NULL
untreated	NULL
C81	NULL
cell	NULL
extract	NULL
(	NULL
C81	NULL
)	NULL
were	NULL
separated	NULL
by	NULL
SDS-gel	NULL
electrophoresis	NULL
followed	NULL
by	NULL
immunoblotting	NULL
with	NULL
monoclonal	NULL
anti-Tax	NULL
antibody	NULL
.	NULL

(	NULL
B	NULL
)	NULL
C81	NULL
cell	NULL
extracts	NULL
were	NULL
immunoprecipitated	NULL
with	NULL
monoclonal	NULL
anti-Tax	NULL
antibody	NULL
(	NULL
anti-Tax	NULL
)	NULL
,	NULL
a	NULL
control	NULL
monoclonal	NULL
antibody	NULL
against	NULL
the	NULL
HA	NULL
epitope	NULL
,	NULL
protein	NULL
A-Sepharose	NULL
beads	NULL
alone	NULL
(	NULL
PAS	NULL
)	NULL
,	NULL
or	NULL
anti-TFIIA	NULL
antibody	NULL
(	NULL
anti-p55	NULL
)	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

Precipitated	NULL
proteins	NULL
were	NULL
analyzed	NULL
by	NULL
SDS-gel	NULL
electrophoresis	NULL
followed	NULL
by	NULL
immunoblotting	NULL
with	NULL
anti-TFIIA	NULL
(	NULL
p55	NULL
)	NULL
antibody	NULL
.	NULL

A-Sepharose	NULL
)	NULL
,	NULL
demonstrating	NULL
the	NULL
specific	NULL
coprecipitation	NULL
of	NULL
Tax	NULL
with	NULL
TFIIA	NULL
(	NULL
Fig	NULL
.	NULL

4B	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
Tax	NULL
and	NULL
TFIIA	NULL
are	NULL
able	NULL
to	NULL
associate	NULL
in	NULL
Tax-expressing	NULL
T	NULL
lymphocytes	NULL
.	NULL

TFIIA	NULL
facilitates	NULL
Tax	NULL
transactivation	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
functional	NULL
requirement	NULL
for	NULL
TFIIA	NULL
in	NULL
Tax	NULL
transactivation	NULL
was	NULL
first	NULL
addressed	NULL
by	NULL
an	NULL
in	NULL
vitro	NULL
transcription	NULL
assay	NULL
.	NULL

Assays	NULL
were	NULL
conducted	NULL
with	NULL
HeLa	NULL
whole-cell	NULL
extracts	NULL
and	NULL
pTRE-1	NULL
;	NULL
,	NULL
,	NULL
a	NULL
super-coiled	NULL
template	NULL
which	NULL
contains	NULL
two	NULL
21-bp	NULL
repeat	NULL
elements	NULL
from	NULL
the	NULL
HTLV-1	NULL
LTR	NULL
placed	NULL
upstream	NULL
of	NULL
the	NULL
chicken	NULL
ovalbumin	NULL
promoter	NULL
and	NULL
a	NULL
G-free	NULL
cassette	NULL
.	NULL

Upon	NULL
addition	NULL
of	NULL
Tax	NULL
,	NULL
transcription	NULL
was	NULL
increased	NULL
approximately	NULL
sixfold	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
.	NULL

Antibody	NULL
specific	NULL
for	NULL
Tax	NULL
neutralized	NULL
this	NULL
effect	NULL
,	NULL
TFIIA-	NULL
-	NULL
Preimmune	NULL
WCE	NULL
depleted	NULL
depleted	NULL
-	NULL
04	NULL
(	NULL
e-	NULL
oa	NULL
)	NULL
-	NULL
4	NULL
%	NULL
10	NULL
20	NULL
3	NULL
4	NULL
50	NULL
6	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

TFIIA	NULL
is	NULL
required	NULL
for	NULL
Tax	NULL
transactivation	NULL
in	NULL
vitro	NULL
.	NULL

In	NULL
vitro	NULL
transcription	NULL
assays	NULL
were	NULL
conducted	NULL
with	NULL
the	NULL
pTRE-1	NULL
;	NULL
,	NULL
plasmid	NULL
,	NULL
which	NULL
contains	NULL
two	NULL
21-bp	NULL
repeats	NULL
from	NULL
the	NULL
HTLV-1	NULL
LTR	NULL
,	NULL
an	NULL
ovalbumin	NULL
promoter	NULL
,	NULL
and	NULL
a	NULL
G-free	NULL
cassette	NULL
(	NULL
see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
(	NULL
101	NULL
)	NULL
.	NULL

HeLa	NULL
WCE	NULL
were	NULL
either	NULL
untreated	NULL
(	NULL
lanes	NULL
1	NULL
and	NULL
2	NULL
)	NULL
,	NULL
depleted	NULL
of	NULL
TFIIA	NULL
by	NULL
preclearing	NULL
the	NULL
WCE	NULL
with	NULL
anti-TFIIA	NULL
antibody	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
,	NULL
or	NULL
precleared	NULL
with	NULL
control	NULL
preimmune	NULL
antibody	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Transactivation	NULL
by	NULL
Tax	NULL
was	NULL
performed	NULL
by	NULL
addition	NULL
of	NULL
baculovirus-generated	NULL
Tax	NULL
(	NULL
lanes	NULL
2	NULL
,	NULL
4	NULL
,	NULL
and	NULL
6	NULL
)	NULL
.	NULL

Tax	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

indicating	NULL
that	NULL
the	NULL
enhanced	NULL
transcription	NULL
is	NULL
Tax	NULL
dependent	NULL
(	NULL
reference	NULL
19	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

When	NULL
the	NULL
extract	NULL
was	NULL
depleted	NULL
of	NULL
TFIIA	NULL
by	NULL
using	NULL
a	NULL
TFIIA-specific	NULL
antibody	NULL
(	NULL
anti-p55	NULL
)	NULL
,	NULL
a	NULL
decrease	NULL
in	NULL
both	NULL
basal	NULL
and	NULL
Tax-transactivated	NULL
transcription	NULL
was	NULL
observed	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

The	NULL
decrease	NULL
in	NULL
basal	NULL
transcription	NULL
to	NULL
background	NULL
levels	NULL
prevented	NULL
an	NULL
accurate	NULL
quantitative	NULL
comparison	NULL
of	NULL
the	NULL
fold	NULL
Tax	NULL
transactivation	NULL
.	NULL

We	NULL
calculate	NULL
,	NULL
however	NULL
,	NULL
that	NULL
the	NULL
level	NULL
of	NULL
Tax-transactivated	NULL
transcription	NULL
in	NULL
the	NULL
TFIIA-depleted	NULL
extract	NULL
was	NULL
reduced	NULL
11-fold	NULL
compared	NULL
with	NULL
that	NULL
of	NULL
the	NULL
untreated	NULL
control	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Treatment	NULL
of	NULL
the	NULL
extract	NULL
with	NULL
preimmune	NULL
serum	NULL
,	NULL
which	NULL
modestly	NULL
reduced	NULL
the	NULL
overall	NULL
level	NULL
of	NULL
basal	NULL
or	NULL
Tax-activated	NULL
transcription	NULL
,	NULL
did	NULL
not	NULL
significantly	NULL
reduce	NULL
the	NULL
level	NULL
of	NULL
Tax	NULL
transactivation	NULL
(	NULL
six-	NULL
to	NULL
sevenfold	NULL
increase	NULL
)	NULL
(	NULL
lanes	NULL
5	NULL
and	NULL
6	NULL
)	NULL
.	NULL

As	NULL
controls	NULL
for	NULL
these	NULL
experiments	NULL
,	NULL
Western	NULL
blot	NULL
analysis	NULL
confirmed	NULL
that	NULL
TFIIA	NULL
was	NULL
absent	NULL
in	NULL
the	NULL
TFIIA	NULL
antibody-depleted	NULL
cell	NULL
extract	NULL
but	NULL
present	NULL
in	NULL
the	NULL
preimmune	NULL
antibody-depleted	NULL
extract	NULL
(	NULL
19	NULL
)	NULL
.	NULL

Further	NULL
,	NULL
when	NULL
purified	NULL
TFIIA	NULL
was	NULL
added	NULL
back	NULL
to	NULL
the	NULL
TFIIA-depleted	NULL
cell	NULL
extract	NULL
Tax	NULL
transactivation	NULL
was	NULL
restored	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
(	NULL
19	NULL
)	NULL
.	NULL

These	NULL
results	NULL
suggest	NULL
that	NULL
TFIIA	NULL
is	NULL
important	NULL
for	NULL
Tax-activated	NULL
transcription	NULL
,	NULL
in	NULL
that	NULL
Tax	NULL
transactivation	NULL
is	NULL
reduced	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
TFIIA	NULL
.	NULL

TFIIA	NULL
enhances	NULL
Tax-mediated	NULL
activation	NULL
in	NULL
vivo	NULL
.	NULL

We	NULL
then	NULL
asked	NULL
if	NULL
TFIIA	NULL
can	NULL
influence	NULL
Tax-activated	NULL
transcription	NULL
in	NULL
vivo	NULL
in	NULL
a	NULL
transient-expression	NULL
assay	NULL
.	NULL

Jurkat	NULL
T	NULL
lymphocytes	NULL
were	NULL
cotransfected	NULL
with	NULL
an	NULL
HTLV-1	NULL
LTR-driven	NULL
CAT	NULL
reporter	NULL
(	NULL
pU3RCAT	NULL
)	NULL
,	NULL
a	NULL
Tax	NULL
expression	NULL
vector	NULL
(	NULL
pCTax	NULL
)	NULL
,	NULL
and	NULL
plasmids	NULL
expressing	NULL
p55	NULL
(	NULL
«	NULL
B	NULL
)	NULL
,	NULL
equivalent	NULL
to	NULL
coexpression	NULL
of	NULL
p35	NULL
(	NULL
«	NULL
)	NULL
and	NULL
p19	NULL
(	NULL
B	NULL
)	NULL
(	NULL
17	NULL
,	NULL
55	NULL
,	NULL
106	NULL
)	NULL
,	NULL
and	NULL
the	NULL
p12	NULL
(	NULL
7	NULL
)	NULL
subunits	NULL
of	NULL
TFIIA	NULL
.	NULL

We	NULL
initially	NULL
established	NULL
conditions	NULL
allowing	NULL
for	NULL
minimal	NULL
levels	NULL
of	NULL
Tax	NULL
transactivation	NULL
such	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
TFIIA	NULL
on	NULL
Tax	NULL
transactivation	NULL
could	NULL
be	NULL
evaluated	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

These	NULL
studies	NULL
demonstrated	NULL
that	NULL
Tax	NULL
activates	NULL
transcription	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
and	NULL
that	NULL
suboptimal	NULL
levels	NULL
of	NULL
Tax	NULL
transactivation	NULL
could	NULL
be	NULL
achieved	NULL
with	NULL
2	NULL
to	NULL
5	NULL
ng	NULL
of	NULL
the	NULL
Tax	NULL
expression	NULL
plasmid	NULL
.	NULL

Upon	NULL
coexpression	NULL
of	NULL
the	NULL
p55	NULL
(	NULL
«	NULL
B	NULL
)	NULL
and	NULL
p12	NULL
(	NULL
y	NULL
)	NULL
TFIIA	NULL
subunits	NULL
,	NULL
Tax-activated	NULL
transcription	NULL
increased	NULL
to	NULL
12-fold	NULL
above	NULL
basal	NULL
levels	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

Importantly	NULL
,	NULL
cotransfection	NULL
of	NULL
the	NULL
p55	NULL
(	NULL
«	NULL
B	NULL
)	NULL
or	NULL
the	NULL
p12	NULL
(	NULL
y	NULL
)	NULL
expression	NULL
plasmid	NULL
with	NULL
pU3RCAT	NULL
and	NULL
pCTax	NULL
failed	NULL
to	NULL
alter	NULL
Tax	NULL
transactivation	NULL
levels	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
known	NULL
functional	NULL
requirement	NULL
for	NULL
all	NULL
three	NULL
TFIIA	NULL
subunits	NULL
(	NULL
Fig	NULL
.	NULL

6B	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
p55	NULL
(	NULL
«	NULL
B	NULL
)	NULL
and	NULL
p12	NULL
(	NULL
7	NULL
)	NULL
subunits	NULL
,	NULL
when	NULL
tested	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
Tax	NULL
,	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
basal	NULL
activity	NULL
of	NULL
the	NULL
LTR	NULL
reporter	NULL
plasmid	NULL
,	NULL
suggesting	NULL
that	NULL
the	NULL
effect	NULL
of	NULL
TFIIA	NULL
on	NULL
LTR	NULL
transcription	NULL
was	NULL
Tax	NULL
dependent	NULL
.	NULL

These	NULL
in	NULL
vivo	NULL
results	NULL
support	NULL
our	NULL
in	NULL
vitro	NULL
observations	NULL
that	NULL
TFIIA	NULL
is	NULL
involved	NULL
in	NULL
Tax-activated	NULL
transcription	NULL
.	NULL

DISCUSSION	NULL
Most	NULL
site-specific	NULL
activators	NULL
are	NULL
modular	NULL
in	NULL
structure	NULL
with	NULL
distinct	NULL
and	NULL
often	NULL
interchangeable	NULL
domains	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
,	NULL
dimerization	NULL
,	NULL
and	NULL
transactivation	NULL
(	NULL
39	NULL
,	NULL
64	NULL
,	NULL
92	NULL
)	NULL
.	NULL

Numerous	NULL
reports	NULL
describe	NULL
a	NULL
physical	NULL
association	NULL
between	NULL
the	NULL
AD	NULL
of	NULL
transactivating	NULL
proteins	NULL
and	NULL
the	NULL
general	NULL
transcription	NULL
factors	NULL
TBP	NULL
,	NULL
TFIIB	NULL
,	NULL
TFIIF	NULL
,	NULL
TFIID	NULL
,	NULL
and	NULL
the	NULL
TFIID	NULL
TAFs	NULL
(	NULL
9	NULL
,	NULL
11	NULL
,	NULL
13	NULL
,	NULL
32	NULL
,	NULL
41	NULL
,	NULL
54	NULL
,	NULL
86	NULL
,	NULL
91	NULL
,	NULL
97	NULL
,	NULL
101	NULL
,	NULL
112	NULL
)	NULL
.	NULL

The	NULL
relevance	NULL
of	NULL
such	NULL
interactions	NULL
has	NULL
been	NULL
supported	NULL
by	NULL
studies	NULL
which	NULL
demonstrate	NULL
by	NULL
mutagenic	NULL
analysis	NULL
that	NULL
loss	NULL
of	NULL
association	NULL
between	NULL
these	NULL
activators	NULL
and	NULL
the	NULL
general	NULL
transcription	NULL
factors	NULL
corresponds	NULL
to	NULL
a	NULL
reduced	NULL
capacity	NULL
of	NULL
the	NULL
transactivator	NULL
to	NULL
stimulate	NULL
transcription	NULL
(	NULL
41	NULL
)	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
provide	NULL
evidence	NULL
for	NULL
a	NULL
physical	NULL
interaction	NULL
between	NULL
Tax	NULL
and	NULL
the	NULL
35-kDa	NULL
(	NULL
«	NULL
)	NULL
subunit	NULL
of	NULL
TFIIA	NULL
by	NULL
using	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
interaction	NULL
system	NULL
,	NULL
by	NULL
association	NULL
of	NULL
GST	NULL
-Tax	NULL
with	NULL
native	NULL
TFIIA	NULL
from	NULL
HeLa	NULL
cells	NULL
,	NULL
and	NULL
by	NULL
coimmunoprecipitation	NULL
of	NULL
Tax	NULL
and	NULL
TFIIA	NULL
in	NULL
Tax-expressing	NULL
T	NULL
lym-	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
20	NULL
A	NULL
1	NULL
18	NULL
2	NULL
3	NULL
C	NULL
<	NULL
T	NULL
0	NULL
S	NULL
6	NULL
LL	NULL
.	NULL

15	NULL
B	NULL
Fold	NULL
Cat	NULL
Activity	NULL
Tax	NULL
(	NULL
ng	NULL
)	NULL
p	NULL
55	NULL
(	NULL
ng	NULL
)	NULL
0	NULL
0	NULL
50	NULL
0	NULL
0	NULL
50	NULL
50	NULL
50	NULL
p12	NULL
(	NULL
ng	NULL
)	NULL
0	NULL
0	NULL
0	NULL
50	NULL
200	NULL
50	NULL
200	NULL
200	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

TFIIA	NULL
enhances	NULL
Tax	NULL
transactivation	NULL
in	NULL
vivo	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Jurkat	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
1	NULL
pg	NULL
of	NULL
pU3RCAT	NULL
and	NULL
0	NULL
to	NULL
10	NULL
ug	NULL
of	NULL
pCTax	NULL
to	NULL
determine	NULL
amounts	NULL
of	NULL
pCTax	NULL
sufficient	NULL
for	NULL
minimal	NULL
Tax	NULL
transactivation	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Jurkat	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
5	NULL
ng	NULL
of	NULL
pCTax	NULL
,	NULL
1	NULL
ug	NULL
of	NULL
pU3RCAT	NULL
,	NULL
0	NULL
to	NULL
50	NULL
ng	NULL
of	NULL
pCMVp35	NULL
(	NULL
aB	NULL
)	NULL
,	NULL
or	NULL
0	NULL
to	NULL
200	NULL
ng	NULL
of	NULL
pCMVp12	NULL
(	NULL
y	NULL
)	NULL
.	NULL

CAT	NULL
activities	NULL
determined	NULL
are	NULL
the	NULL
mean	NULL
of	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

phocytes	NULL
.	NULL

We	NULL
also	NULL
demonstrate	NULL
that	NULL
TFIIA	NULL
can	NULL
enhance	NULL
Tax-activated	NULL
transcription	NULL
from	NULL
a	NULL
Tax-responsive	NULL
promoter	NULL
in	NULL
vitro	NULL
and	NULL
from	NULL
the	NULL
HTLV-1	NULL
LTR	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

This	NULL
enhanced	NULL
activation	NULL
appears	NULL
to	NULL
be	NULL
specific	NULL
to	NULL
the	NULL
interaction	NULL
of	NULL
TFIIA	NULL
with	NULL
Tax	NULL
,	NULL
since	NULL
Tax	NULL
failed	NULL
to	NULL
interact	NULL
with	NULL
TBP	NULL
or	NULL
TFIIB	NULL
.	NULL

Interestingly	NULL
,	NULL
we	NULL
identified	NULL
two	NULL
previously	NULL
characterized	NULL
(	NULL
84	NULL
)	NULL
activation-defective	NULL
point	NULL
mutants	NULL
of	NULL
Tax	NULL
,	NULL
M32	NULL
(	NULL
Y¥196A	NULL
,	NULL
K1978	NULL
)	NULL
and	NULL
M41	NULL
(	NULL
H287A	NULL
,	NULL
P288S	NULL
)	NULL
,	NULL
which	NULL
were	NULL
unable	NULL
to	NULL
interact	NULL
with	NULL
TFIIA	NULL
in	NULL
the	NULL
yeast	NULL
two-hybrid	NULL
assay	NULL
.	NULL

When	NULL
tested	NULL
in	NULL
the	NULL
GST-binding	NULL
assay	NULL
,	NULL
the	NULL
M32	NULL
mutant	NULL
showed	NULL
a	NULL
20-fold	NULL
reduction	NULL
in	NULL
TFIIA	NULL
binding	NULL
compared	NULL
with	NULL
wild-type	NULL
Tax	NULL
.	NULL

Localizing	NULL
the	NULL
region	NULL
(	NULL
s	NULL
)	NULL
of	NULL
Tax	NULL
critical	NULL
to	NULL
its	NULL
activation	NULL
function	NULL
has	NULL
been	NULL
hindered	NULL
by	NULL
the	NULL
pleiotropic	NULL
nature	NULL
of	NULL
Tax	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
mutagenesis	NULL
within	NULL
multiple	NULL
regions	NULL
of	NULL
Tax	NULL
often	NULL
renders	NULL
the	NULL
protein	NULL
transcriptionally	NULL
inactive	NULL
,	NULL
further	NULL
complicating	NULL
the	NULL
structure-function	NULL
analysis	NULL
of	NULL
Tax	NULL
(	NULL
80	NULL
,	NULL
84	NULL
,	NULL
93	NULL
)	NULL
.	NULL

Nev-ertheless	NULL
,	NULL
several	NULL
studies	NULL
involving	NULL
Tax	NULL
point	NULL
and	NULL
deletion	NULL
mutants	NULL
have	NULL
succeeded	NULL
in	NULL
segregating	NULL
and	NULL
assigning	NULL
functions	NULL
to	NULL
different	NULL
domains	NULL
of	NULL
Tax	NULL
(	NULL
84	NULL
)	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
HTLV-1	NULL
LTR	NULL
,	NULL
mediated	NULL
by	NULL
CREB	NULL
,	NULL
is	NULL
affected	NULL
by	NULL
mutations	NULL
in	NULL
the	NULL
HTLV-1	NULL
Tax	NULL
TRANSACTIVATOR	NULL
INTERACTION	NULL
WITH	NULL
TFIIA	NULL
4661	NULL
amino	NULL
and	NULL
carboxy	NULL
termini	NULL
,	NULL
while	NULL
transactivation	NULL
of	NULL
the	NULL
HIV-1	NULL
LTR	NULL
,	NULL
involving	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
is	NULL
sensitive	NULL
to	NULL
mutations	NULL
in	NULL
the	NULL
central	NULL
region	NULL
of	NULL
Tax	NULL
.	NULL

One	NULL
approach	NULL
used	NULL
to	NULL
define	NULL
the	NULL
minimal	NULL
activation	NULL
domain	NULL
of	NULL
Tax	NULL
has	NULL
been	NULL
to	NULL
fuse	NULL
different	NULL
domains	NULL
of	NULL
Tax	NULL
to	NULL
a	NULL
heterol-ogous	NULL
DBD	NULL
.	NULL

One	NULL
such	NULL
study	NULL
in	NULL
which	NULL
GAL4-Tax	NULL
was	NULL
used	NULL
to	NULL
activate	NULL
transcription	NULL
from	NULL
a	NULL
minimal	NULL
promoter	NULL
with	NULL
upstream	NULL
GALA4-binding	NULL
sites	NULL
found	NULL
that	NULL
amino	NULL
acids	NULL
289	NULL
to	NULL
320	NULL
of	NULL
Tax	NULL
defined	NULL
the	NULL
minimal	NULL
AD	NULL
,	NULL
although	NULL
flanking	NULL
regions	NULL
of	NULL
Tax	NULL
enhanced	NULL
this	NULL
effect	NULL
(	NULL
79	NULL
)	NULL
.	NULL

A	NULL
second	NULL
study	NULL
involving	NULL
GAL4-Tax	NULL
concluded	NULL
that	NULL
two	NULL
contiguous	NULL
domains	NULL
of	NULL
Tax	NULL
encompassing	NULL
amino	NULL
acids	NULL
2	NULL
to	NULL
255	NULL
and	NULL
227	NULL
to	NULL
337	NULL
were	NULL
required	NULL
for	NULL
Tax-activated	NULL
transcription	NULL
(	NULL
93	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
M32	NULL
(	NULL
Y¥196A	NULL
,	NULL
K1978	NULL
)	NULL
and	NULL
M41	NULL
(	NULL
H287A	NULL
,	NULL
P288S	NULL
)	NULL
mutants	NULL
,	NULL
which	NULL
failed	NULL
to	NULL
interact	NULL
with	NULL
the	NULL
55-kDa	NULL
(	NULL
«	NULL
B	NULL
)	NULL
or	NULL
35-kDa	NULL
(	NULL
«	NULL
)	NULL
subunits	NULL
of	NULL
TFIIA	NULL
,	NULL
are	NULL
defective	NULL
in	NULL
transactivating	NULL
both	NULL
the	NULL
HIV-1	NULL
and	NULL
HTLV-1	NULL
LTRs	NULL
.	NULL

These	NULL
mutants	NULL
may	NULL
interfere	NULL
with	NULL
Tax-TFIIA	NULL
association	NULL
either	NULL
by	NULL
disrupting	NULL
the	NULL
structure	NULL
of	NULL
a	NULL
limited	NULL
region	NULL
of	NULL
Tax	NULL
that	NULL
is	NULL
required	NULL
for	NULL
this	NULL
interaction	NULL
or	NULL
by	NULL
exerting	NULL
a	NULL
more	NULL
global	NULL
effect	NULL
on	NULL
the	NULL
structural	NULL
integrity	NULL
of	NULL
the	NULL
Tax	NULL
protein	NULL
.	NULL

Significantly	NULL
,	NULL
the	NULL
M32	NULL
(	NULL
Y196A	NULL
,	NULL
K1978	NULL
)	NULL
mutation	NULL
resides	NULL
within	NULL
a	NULL
region	NULL
of	NULL
Tax	NULL
rendered	NULL
transcriptionally	NULL
inactive	NULL
by	NULL
mutagenesis	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutants	NULL
altered	NULL
in	NULL
Tax	NULL
immediately	NULL
surrounding	NULL
the	NULL
M41	NULL
(	NULL
H287A	NULL
,	NULL
P288S	NULL
)	NULL
point	NULL
mutant	NULL
,	NULL
such	NULL
as	NULL
M39	NULL
,	NULL
M40	NULL
,	NULL
M42	NULL
,	NULL
and	NULL
M43	NULL
(	NULL
84	NULL
)	NULL
,	NULL
show	NULL
nearly	NULL
wild-type	NULL
levels	NULL
of	NULL
transactivation	NULL
from	NULL
both	NULL
LTRs	NULL
.	NULL

It	NULL
is	NULL
therefore	NULL
possible	NULL
that	NULL
the	NULL
M32	NULL
mutation	NULL
affects	NULL
a	NULL
region	NULL
of	NULL
Tax	NULL
critical	NULL
to	NULL
the	NULL
structural	NULL
integrity	NULL
of	NULL
the	NULL
protein	NULL
.	NULL

The	NULL
M41	NULL
mutant	NULL
,	NULL
within	NULL
the	NULL
minimal	NULL
activation	NULL
domain	NULL
,	NULL
may	NULL
be	NULL
important	NULL
for	NULL
interaction	NULL
with	NULL
TFIIA	NULL
.	NULL

It	NULL
is	NULL
important	NULL
to	NULL
note	NULL
that	NULL
the	NULL
M21	NULL
and	NULL
M30	NULL
mutants	NULL
,	NULL
defective	NULL
in	NULL
transactivation	NULL
of	NULL
both	NULL
the	NULL
HIV-1	NULL
and	NULL
HTLV-1	NULL
LTRs	NULL
(	NULL
84	NULL
)	NULL
,	NULL
interacted	NULL
with	NULL
TFIIA	NULL
in	NULL
the	NULL
two-hybrid	NULL
assay	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
Tax-activated	NULL
transcription	NULL
requires	NULL
the	NULL
interaction	NULL
of	NULL
Tax	NULL
with	NULL
other	NULL
transcription	NULL
factors	NULL
in	NULL
addition	NULL
to	NULL
TFIIA	NULL
and	NULL
that	NULL
the	NULL
M21	NULL
and	NULL
M30	NULL
Tax	NULL
mutants	NULL
are	NULL
deficient	NULL
in	NULL
this	NULL
interaction	NULL
.	NULL

For	NULL
example	NULL
,	NULL
Tax	NULL
may	NULL
interact	NULL
with	NULL
TAFs	NULL
or	NULL
other	NULL
proteins	NULL
which	NULL
constitute	NULL
the	NULL
holoenzyme	NULL
.	NULL

TFIIA	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
enhance	NULL
the	NULL
stability	NULL
of	NULL
TFIID-promoter	NULL
complexes	NULL
as	NULL
well	NULL
as	NULL
to	NULL
preclude	NULL
the	NULL
association	NULL
of	NULL
inhibitors	NULL
that	NULL
target	NULL
TBP	NULL
.	NULL

The	NULL
Epstein-Barr	NULL
virus	NULL
transactivator	NULL
Zta	NULL
and	NULL
the	NULL
C-terminal	NULL
domain	NULL
of	NULL
VP16	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
stabilize	NULL
and	NULL
increase	NULL
the	NULL
rate	NULL
of	NULL
formation	NULL
of	NULL
DNA-TFIID-TFIIA	NULL
complexes	NULL
upon	NULL
which	NULL
functional	NULL
preinitiation	NULL
complexes	NULL
are	NULL
assembled	NULL
(	NULL
10	NULL
,	NULL
49	NULL
)	NULL
.	NULL

Zta	NULL
,	NULL
which	NULL
,	NULL
like	NULL
Tax	NULL
,	NULL
lacks	NULL
a	NULL
classical	NULL
transactivation	NULL
domain	NULL
,	NULL
interacts	NULL
with	NULL
the	NULL
p55	NULL
(	NULL
«	NULL
B	NULL
)	NULL
subunit	NULL
of	NULL
TFIIA	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
C-terminal	NULL
domain	NULL
of	NULL
the	NULL
acidic	NULL
activator	NULL
VP16	NULL
interacts	NULL
with	NULL
the	NULL
p12	NULL
(	NULL
7	NULL
)	NULL
TFIIA	NULL
subunit	NULL
.	NULL

A	NULL
distinct	NULL
and	NULL
more	NULL
N-terminal	NULL
activation	NULL
domain	NULL
of	NULL
VP16	NULL
fails	NULL
to	NULL
interact	NULL
with	NULL
TFIIA	NULL
,	NULL
suggesting	NULL
that	NULL
contact	NULL
with	NULL
TFIIA	NULL
represents	NULL
only	NULL
one	NULL
of	NULL
the	NULL
pathways	NULL
through	NULL
which	NULL
VP16	NULL
operates	NULL
(	NULL
49	NULL
)	NULL
.	NULL

Since	NULL
TFIIA	NULL
is	NULL
required	NULL
for	NULL
many	NULL
,	NULL
if	NULL
not	NULL
all	NULL
,	NULL
activators	NULL
to	NULL
stimulate	NULL
transcription	NULL
,	NULL
the	NULL
requirement	NULL
may	NULL
not	NULL
be	NULL
manifested	NULL
as	NULL
an	NULL
activator	NULL
interaction	NULL
in	NULL
some	NULL
cases	NULL
.	NULL

Since	NULL
Tax	NULL
operates	NULL
through	NULL
contact	NULL
with	NULL
DNA-binding	NULL
transactivators	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
synergy	NULL
plays	NULL
an	NULL
important	NULL
role	NULL
in	NULL
Tax-mediated	NULL
transactivation	NULL
.	NULL

Indeed	NULL
,	NULL
interactions	NULL
between	NULL
Tax	NULL
and	NULL
several	NULL
site-specific	NULL
activators	NULL
,	NULL
which	NULL
may	NULL
interact	NULL
with	NULL
the	NULL
general	NULL
transcription	NULL
factors	NULL
,	NULL
have	NULL
been	NULL
described	NULL
.	NULL

For	NULL
example	NULL
,	NULL
CREB	NULL
,	NULL
which	NULL
is	NULL
involved	NULL
in	NULL
Tax-mediated	NULL
activation	NULL
,	NULL
interacts	NULL
with	NULL
both	NULL
TFIIB	NULL
,	NULL
perhaps	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
CREB-binding	NULL
protein	NULL
,	NULL
as	NULL
well	NULL
as	NULL
with	NULL
TFIID	NULL
(	NULL
21	NULL
,	NULL
102	NULL
)	NULL
.	NULL

Our	NULL
results	NULL
suggest	NULL
that	NULL
Tax	NULL
can	NULL
interact	NULL
with	NULL
TFIIA	NULL
through	NULL
the	NULL
35-kDa	NULL
(	NULL
a	NULL
)	NULL
subunit	NULL
.	NULL

Hence	NULL
,	NULL
it	NULL
is	NULL
possible	NULL
that	NULL
the	NULL
multimeric	NULL
Tax-CREB-CBP	NULL
complex	NULL
targets	NULL
multiple	NULL
components	NULL
of	NULL
the	NULL
transcription	NULL
initiation	NULL
complex	NULL
including	NULL
TFIIA	NULL
,	NULL
TFIIB	NULL
,	NULL
and	NULL
TFIID	NULL
.	NULL

The	NULL
Tax-CREB	NULL
interaction	NULL
,	NULL
as	NULL
well	NULL
as	NULL
their	NULL
indepen-	NULL
4662	NULL
CLEMENS	NULL
ET	NULL
AL	NULL
.	NULL

dent	NULL
interactions	NULL
with	NULL
the	NULL
transcriptional	NULL
machinery	NULL
,	NULL
may	NULL
confer	NULL
a	NULL
greater	NULL
stability	NULL
on	NULL
this	NULL
multiprotein	NULL
complex	NULL
,	NULL
allowing	NULL
for	NULL
the	NULL
subsequent	NULL
addition	NULL
of	NULL
the	NULL
remaining	NULL
transcription	NULL
factors	NULL
.	NULL

Alternatively	NULL
,	NULL
the	NULL
Tax-CREB	NULL
component	NULL
may	NULL
structurally	NULL
modify	NULL
the	NULL
transcription	NULL
complex	NULL
such	NULL
that	NULL
enhanced	NULL
transcription	NULL
from	NULL
CRE-containing	NULL
Tax-responsive	NULL
promoters	NULL
is	NULL
favored	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
We	NULL
thank	NULL
Ramin	NULL
Shiekhattar	NULL
and	NULL
Fatah	NULL
Kashanchi	NULL
for	NULL
sharing	NULL
unpublished	NULL
data	NULL
regarding	NULL
the	NULL
interaction	NULL
of	NULL
Tax	NULL
with	NULL
different	NULL
general	NULL
transcription	NULL
factors	NULL
.	NULL

We	NULL
also	NULL
thank	NULL
Jiirgen	NULL
Dittmer	NULL
for	NULL
a	NULL
critical	NULL
evaluation	NULL
of	NULL
the	NULL
manuscript	NULL
and	NULL
other	NULL
members	NULL
of	NULL
the	NULL
Laboratory	NULL
of	NULL
Molecular	NULL
Virology	NULL
for	NULL
helpful	NULL
discussions	NULL
.	NULL

10	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

REFERENCES	NULL
.	NULL

Adya	NULL
,	NULL
N.	NULL
,	NULL
and	NULL
C.-Z	NULL
.	NULL

Giam	NULL
.	NULL

1995	NULL
.	NULL

Distinct	NULL
regions	NULL
in	NULL
human	NULL
T-cell	NULL
lympho-	NULL
tropic	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
mediate	NULL
interactions	NULL
with	NULL
activator	NULL
protein	NULL
CREB	NULL
and	NULL
basal	NULL
transcription	NULL
factors	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:1834-1841.	NULL
.	NULL

Alexandre	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
B.	NULL
Verrier	NULL
.	NULL

1991	NULL
.	NULL

Four	NULL
regulatory	NULL
elements	NULL
in	NULL
the	NULL
human	NULL
c-fos	NULL
promoter	NULL
mediate	NULL
transactivation	NULL
by	NULL
HTLV-1	NULL
tax	NULL
protein	NULL
.	NULL

Oncogene	NULL
6:543-551.	NULL
.	NULL

Auble	NULL
,	NULL
D.	NULL
T.	NULL
,	NULL
and	NULL
S.	NULL
Hahn	NULL
.	NULL

1993	NULL
.	NULL

An	NULL
ATP-dependent	NULL
inhibitor	NULL
of	NULL
TBP	NULL
binding	NULL
to	NULL
DNA	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:844-856.	NULL
.	NULL

Baranger	NULL
,	NULL
A.	NULL
M.	NULL
,	NULL
C.	NULL
R.	NULL
Palmer	NULL
,	NULL
M.	NULL
K.	NULL
Hamm	NULL
,	NULL
H.	NULL
A.	NULL
Giebler	NULL
,	NULL
A.	NULL
Brauweiler	NULL
,	NULL
J.	NULL
K.	NULL
Nyborg	NULL
,	NULL
and	NULL
A.	NULL
Schepartz	NULL
.	NULL

1995	NULL
.	NULL

Mechanism	NULL
of	NULL
DNA-binding	NULL
enhancement	NULL
by	NULL
the	NULL
human	NULL
T-cell	NULL
leukaemia	NULL
virus	NULL
transactivator	NULL
Tax	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
376:606-608.	NULL
.	NULL

Beimling	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
K.	NULL
Moelling	NULL
.	NULL

1992	NULL
.	NULL

Direct	NULL
interaction	NULL
of	NULL
CREB	NULL
protein	NULL
with	NULL
21	NULL
bp	NULL
Tax-response	NULL
elements	NULL
of	NULL
HTLV-1	NULL
LTR	NULL
.	NULL

Oncogene	NULL
7:257-262.	NULL
.	NULL

Beraud	NULL
,	NULL
C.	NULL
,	NULL
S.	NULL
Sun	NULL
,	NULL
P.	NULL
Ganchi	NULL
,	NULL
D.	NULL
Ballard	NULL
,	NULL
and	NULL
W.	NULL
Greene	NULL
.	NULL

1994	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
associates	NULL
with	NULL
and	NULL
is	NULL
negatively	NULL
regulated	NULL
by	NULL
the	NULL
NF-xB2	NULL
p100	NULL
gene	NULL
product	NULL
:	NULL
implications	NULL
for	NULL
viral	NULL
latency	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:1374-1382.	NULL
.	NULL

Buratowski	NULL
,	NULL
S.	NULL
,	NULL
S.	NULL
Hahn	NULL
,	NULL
L.	NULL
Guarente	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1989	NULL
.	NULL

Five	NULL
inter	NULL
mediate	NULL
complexes	NULL
in	NULL
transcription	NULL
initiation	NULL
by	NULL
RNA	NULL
polymerase	NULL
IL	NULL
Cell	NULL
56:549-561.	NULL
.	NULL

Caron	NULL
,	NULL
C.	NULL
,	NULL
R.	NULL
Rousset	NULL
,	NULL
C.	NULL
Beraud	NULL
,	NULL
V.	NULL
Moncollin	NULL
,	NULL
J.-M.	NULL
Egly	NULL
,	NULL
and	NULL
P.	NULL
Jalinot	NULL
.	NULL

1993	NULL
.	NULL

Functional	NULL
and	NULL
biochemical	NULL
interaction	NULL
of	NULL
the	NULL
HTLV-1	NULL
Tax1	NULL
transactivator	NULL
with	NULL
TBP	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

12:4269-4278.	NULL
.	NULL

Chen	NULL
,	NULL
J.	NULL
,	NULL
L.	NULL
D.	NULL
Attardi	NULL
,	NULL
C.	NULL
P.	NULL
Verrijzer	NULL
,	NULL
K.	NULL
Yokomori	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1994	NULL
.	NULL

Assembly	NULL
of	NULL
recombinant	NULL
TFIID	NULL
reveals	NULL
differential	NULL
coactivator	NULL
requirements	NULL
for	NULL
distinct	NULL
transcriptional	NULL
activators	NULL
.	NULL

Cell	NULL
79:93-105	NULL
.	NULL

Chi	NULL
,	NULL
T.	NULL
,	NULL
P.	NULL
Lieberman	NULL
,	NULL
K.	NULL
Ellwood	NULL
,	NULL
and	NULL
M.	NULL
Carey	NULL
.	NULL

1955	NULL
.	NULL

A	NULL
general	NULL
mechanism	NULL
for	NULL
transcriptional	NULL
synergy	NULL
by	NULL
eucaryotic	NULL
activators	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
377:254-257	NULL
.	NULL

Chiang	NULL
,	NULL
C.-M.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1995	NULL
.	NULL

Cloning	NULL
of	NULL
an	NULL
intrinsic	NULL
human	NULL
TFIID	NULL
subunit	NULL
that	NULL
interacts	NULL
with	NULL
multiple	NULL
transcriptional	NULL
activators	NULL
.	NULL

Science	NULL
267:531-536	NULL
.	NULL

Choy	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1993	NULL
.	NULL

Eukaryotic	NULL
activators	NULL
function	NULL
during	NULL
multiple	NULL
steps	NULL
of	NULL
preinitiation	NULL
complex	NULL
assembly	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
366	NULL
:	NULL
531-536	NULL
.	NULL

Colgan	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
Wampler	NULL
,	NULL
and	NULL
J.	NULL
L.	NULL
Manley	NULL
.	NULL

1993	NULL
.	NULL

Interaction	NULL
between	NULL
a	NULL
transcriptional	NULL
activator	NULL
and	NULL
transcription	NULL
factor	NULL
IIB	NULL
in	NULL
vivo	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
362:549-553	NULL
.	NULL

Crenon	NULL
,	NULL
L	NULL
,	NULL
C.	NULL
Beraud	NULL
,	NULL
P.	NULL
Simard	NULL
,	NULL
J.	NULL
Montagne	NULL
,	NULL
P.	NULL
Veschambre	NULL
,	NULL
and	NULL
P.	NULL
Jalinot	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
transcriptionally	NULL
active	NULL
factors	NULL
mediating	NULL
the	NULL
effect	NULL
of	NULL
the	NULL
HTLV-I	NULL
Tax	NULL
transactivator	NULL
on	NULL
the	NULL
IL-2R	NULL
alpha	NULL
kappa	NULL
B	NULL
enhancer	NULL
include	NULL
the	NULL
product	NULL
of	NULL
the	NULL
c-rel	NULL
proto-oncogene	NULL
.	NULL

Oncogene	NULL
8:867-875	NULL
.	NULL

Cross	NULL
,	NULL
S.	NULL
L.	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Wolf	NULL
,	NULL
N.	NULL
J.	NULL
Holbrook	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
W.	NULL
J.	NULL
Leonard	NULL
.	NULL

1987	NULL
.	NULL

Regulation	NULL
of	NULL
the	NULL
human	NULL
interleukin-2	NULL
receptor	NULL
a	NULL
chain	NULL
promoter	NULL
:	NULL
activation	NULL
of	NULL
a	NULL
non-functional	NULL
promoter	NULL
by	NULL
the	NULL
transactivator	NULL
gene	NULL
of	NULL
HTLV-I	NULL
.	NULL

Cell	NULL
49:47-56	NULL
.	NULL

DeJong	NULL
,	NULL
J.	NULL
,	NULL
R.	NULL
Bernstein	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1995	NULL
.	NULL

Human	NULL
general	NULL
transcription	NULL
factor	NULL
TFIIA	NULL
:	NULL
characterization	NULL
of	NULL
a	NULL
cDNA	NULL
encoding	NULL
the	NULL
small	NULL
subunit	NULL
and	NULL
requirement	NULL
for	NULL
basal	NULL
and	NULL
activated	NULL
transcription	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:3313-3317	NULL
.	NULL

DeJong	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1993	NULL
.	NULL

A	NULL
single	NULL
cDNA	NULL
,	NULL
hTFIA/a	NULL
,	NULL
encodes	NULL
both	NULL
the	NULL
p35	NULL
and	NULL
p19	NULL
subunits	NULL
of	NULL
human	NULL
TFIIA	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2220-2234	NULL
.	NULL

Dittmer	NULL
,	NULL
J.	NULL
,	NULL
S.	NULL
D.	NULL
Gitlin	NULL
,	NULL
R.	NULL
L.	NULL
Reid	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Brady	NULL
.	NULL

1993	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
P2	NULL
promoter	NULL
of	NULL
the	NULL
parathyroid	NULL
hormone	NULL
related	NULL
protein	NULL
(	NULL
PTHrP	NULL
)	NULL
by	NULL
HTLV-I	NULL
Tax	NULL
;	NULL
:	NULL
evidence	NULL
for	NULL
the	NULL
involvement	NULL
of	NULL
transcription	NULL
factor	NULL
Ets-1	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

67:6087-6095	NULL
.	NULL

Duvall	NULL
,	NULL
J.	NULL
F.	NULL
,	NULL
F.	NULL
Kashanchi	NULL
,	NULL
A.	NULL
Cvekl	NULL
,	NULL
M.	NULL
F.	NULL
Radonovich	NULL
,	NULL
G.	NULL
Piras	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Brady	NULL
.	NULL

1995	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
HTLV-I	NULL
Tax1-responsive	NULL
21	NULL
bp	NULL
repeats	NULL
requires	NULL
holo-TFIID	NULL
and	NULL
TFIIA	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:5077-5086	NULL
.	NULL

Duyao	NULL
,	NULL
M.	NULL
P.	NULL
,	NULL
D.	NULL
J.	NULL
Kessler	NULL
,	NULL
D.	NULL
B.	NULL
Spicer	NULL
,	NULL
C.	NULL
Bartholomew	NULL
,	NULL
J.	NULL
L.	NULL
Cleveland	NULL
,	NULL
M.	NULL
Siekevitz	NULL
,	NULL
and	NULL
G.	NULL
E.	NULL
Sonenshein	NULL
.	NULL

1992	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
c-myc	NULL
21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

promoter	NULL
by	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
tax	NULL
is	NULL
mediated	NULL
by	NULL
NFxB	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267:16288-16291	NULL
.	NULL

Ferreri	NULL
,	NULL
K.	NULL
,	NULL
G.	NULL
Gill	NULL
,	NULL
and	NULL
M.	NULL
Montminy	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
cAMP-regulated	NULL
transcription	NULL
factor	NULL
CREB	NULL
interacts	NULL
with	NULL
a	NULL
component	NULL
of	NULL
the	NULL
TFIID	NULL
complex	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:1210-1213	NULL
.	NULL

Franklin	NULL
,	NULL
A	NULL
.	NULL

A.	NULL
,	NULL
M.	NULL
F.	NULL
Kubik	NULL
,	NULL
M.	NULL
N.	NULL
Uittenbogaard	NULL
,	NULL
A.	NULL
Brauweiler	NULL
,	NULL
P.	NULL
Utaisincharoen	NULL
,	NULL
M.	NULL
A.	NULL
Matthews	NULL
,	NULL
W.	NULL
S.	NULL
Dynan	NULL
,	NULL
J.	NULL
P.	NULL
Hoeffler	NULL
,	NULL
and	NULL
J.	NULL
K.	NULL
Nyborg	NULL
.	NULL

1993	NULL
.	NULL

Transactivation	NULL
by	NULL
the	NULL
human	NULL
t-cell	NULL
leukemia	NULL
virus	NULL
Tax	NULL
protein	NULL
is	NULL
mediated	NULL
through	NULL
enhanced	NULL
binding	NULL
of	NULL
activating	NULL
transcription	NULL
factor-2	NULL
(	NULL
ATF-2	NULL
)	NULL
ATF-2	NULL
response	NULL
and	NULL
cAMP	NULL
element-binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:21225-21231	NULL
.	NULL

Fujii	NULL
,	NULL
M.	NULL
,	NULL
T.	NULL
Chubjo	NULL
,	NULL
T.	NULL
Minamino	NULL
,	NULL
N.	NULL
Masaaki	NULL
,	NULL
K.	NULL
Miyamoto	NULL
,	NULL
and	NULL
M.	NULL
Seiki	NULL
.	NULL

1995	NULL
.	NULL

Identification	NULL
of	NULL
the	NULL
Tax	NULL
interaction	NULL
region	NULL
of	NULL
serum	NULL
response	NULL
factor	NULL
that	NULL
mediates	NULL
the	NULL
aberrant	NULL
induction	NULL
of	NULL
immediate-early	NULL
genes	NULL
through	NULL
CArG	NULL
boxes	NULL
by	NULL
HTLV-1	NULL
Tax	NULL
.	NULL

Oncogene	NULL
11:7-14	NULL
.	NULL

Fujii	NULL
,	NULL
M.	NULL
,	NULL
P.	NULL
Sassone-Corsi	NULL
,	NULL
and	NULL
I.	NULL
M.	NULL
Verma	NULL
.	NULL

1988.	NULL
c-fos	NULL
promoter	NULL
transactivation	NULL
by	NULL
the	NULL
tax	NULL
,	NULL
protein	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
85:8526-8530	NULL
.	NULL

Fujii	NULL
,	NULL
M.	NULL
,	NULL
H.	NULL
Tsuchiya	NULL
,	NULL
T.	NULL
Chubjo	NULL
,	NULL
T.	NULL
Akizawa	NULL
,	NULL
and	NULL
M.	NULL
Seiki	NULL
.	NULL

1992	NULL
.	NULL

Interaction	NULL
of	NULL
HTLV-I	NULL
Tax	NULL
,	NULL
with	NULL
p67°	NULL
``	NULL
``	NULL
causes	NULL
the	NULL
aberrant	NULL
induction	NULL
of	NULL
cellular	NULL
immediate	NULL
early	NULL
genes	NULL
through	NULL
CArG	NULL
boxes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

62066-2076	NULL
.	NULL

Fujisawa	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Toita	NULL
,	NULL
T.	NULL
Yoshimura	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1991	NULL
.	NULL

The	NULL
indirect	NULL
association	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
Tax	NULL
protein	NULL
with	NULL
DNA	NULL
results	NULL
in	NULL
transcriptional	NULL
activation	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

65:4525-4528	NULL
.	NULL

Ge	NULL
,	NULL
H.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1994	NULL
.	NULL

Purification	NULL
,	NULL
cloning	NULL
,	NULL
and	NULL
characterization	NULL
of	NULL
a	NULL
human	NULL
coactivator	NULL
,	NULL
PC4	NULL
,	NULL
that	NULL
mediates	NULL
transcriptional	NULL
activation	NULL
of	NULL
class	NULL
II	NULL
genes	NULL
.	NULL

Cell	NULL
78:513-523	NULL
.	NULL

Gessain	NULL
,	NULL
A.	NULL
,	NULL
F.	NULL
Barin	NULL
,	NULL
J.	NULL
C.	NULL
Vernant	NULL
,	NULL
O.	NULL
Gaut	NULL
,	NULL
L.	NULL
Maurs	NULL
,	NULL
A.	NULL
Calender	NULL
,	NULL
and	NULL
G.	NULL
de	NULL
The	NULL
.	NULL

1985	NULL
.	NULL

Antibodies	NULL
to	NULL
human	NULL
T	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
in	NULL
patients	NULL
with	NULL
tropical	NULL
spastic	NULL
paraparesis	NULL
.	NULL

Lancet	NULL
ii:407-409	NULL
.	NULL

Gietz	NULL
,	NULL
D.	NULL
,	NULL
A.	NULL
St.	NULL
Jean	NULL
,	NULL
R.	NULL
A	NULL
.	NULL

Woods	NULL
,	NULL
and	NULL
R.	NULL
H.	NULL
Schiestl	NULL
1992	NULL
.	NULL

Improved	NULL
method	NULL
for	NULL
high	NULL
efficiency	NULL
transformation	NULL
of	NULL
intact	NULL
yeast	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:1425	NULL
.	NULL

Ginsberg	NULL
,	NULL
D.	NULL
,	NULL
G.	NULL
Vairo	NULL
,	NULL
T.	NULL
Chittenden	NULL
,	NULL
Z.	NULL
Xiao	NULL
,	NULL
G.	NULL
Xu	NULL
,	NULL
K.	NULL
L.	NULL
Wydner	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
DeCaprio	NULL
,	NULL
J	NULL
.	NULL

B.	NULL
Lawrence	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Livingston	NULL
.	NULL

1994	NULL
.	NULL

E2F-4	NULL
,	NULL
a	NULL
new	NULL
member	NULL
of	NULL
the	NULL
E2F	NULL
transcription	NULL
factor	NULL
family	NULL
,	NULL
interacts	NULL
with	NULL
p107	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:2665-2679	NULL
.	NULL

Golemis	NULL
,	NULL
E.	NULL
M.	NULL
,	NULL
J.	NULL
Gyuris	NULL
,	NULL
and	NULL
R.	NULL
Brent	NULL
.	NULL

1994	NULL
.	NULL

Interaction	NULL
trap/two-hybrid	NULL
system	NULL
to	NULL
identify	NULL
interacting	NULL
proteins	NULL
,	NULL
p.	NULL
13.14.1-13.14.17	NULL
.	NULL

In	NULL
F.	NULL
A.	NULL
Ausubel	NULL
,	NULL
R.	NULL
Brent	NULL
,	NULL
D.	NULL
D.	NULL
Kingston	NULL
,	NULL
J.	NULL
G.	NULL
Moore	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Seidman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Smith	NULL
,	NULL
and	NULL
D.	NULL
Struhl	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Current	NULL
protocols	NULL
in	NULL
molecular	NULL
biology	NULL
.	NULL

Greene	NULL
Publishing	NULL
Associates	NULL
and	NULL
Wiley-Interscience	NULL
,	NULL
New	NULL
York	NULL
.	NULL

31a.Goodrich	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
G.	NULL
Cutler	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1996	NULL
.	NULL

Contacts	NULL
in	NULL
context	NULL
:	NULL
pro	NULL
32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42.	NULL
moter	NULL
specificity	NULL
and	NULL
macromolecular	NULL
interactions	NULL
in	NULL
transcription	NULL
.	NULL

Cell	NULL
84:825-830	NULL
.	NULL

Goodrich	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
T.	NULL
Hoey	NULL
,	NULL
C.	NULL
Thut	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1993	NULL
.	NULL

Drosophilia	NULL
TAFII4O	NULL
interacts	NULL
with	NULL
both	NULL
a	NULL
VP16	NULL
activation	NULL
domain	NULL
and	NULL
basal	NULL
transcription	NULL
factor	NULL
TFIIB	NULL
.	NULL

Cell	NULL
75:519-530	NULL
.	NULL

Goren	NULL
,	NULL
I.	NULL
,	NULL
O.	NULL
J.	NULL
Semmes	NULL
,	NULL
K.	NULL
T.	NULL
Jeang	NULL
,	NULL
and	NULL
K.	NULL
Moelling	NULL
.	NULL

1995	NULL
.	NULL

The	NULL
amino	NULL
terminus	NULL
of	NULL
Tax	NULL
is	NULL
required	NULL
for	NULL
interaction	NULL
with	NULL
the	NULL
cyclic	NULL
AMP	NULL
response	NULL
clement	NULL
binding	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:5806-5811	NULL
.	NULL

Grassmann	NULL
,	NULL
R.	NULL
,	NULL
C.	NULL
Dengler	NULL
,	NULL
I.	NULL
Muller-Fleckenstein	NULL
,	NULL
B.	NULL
Fleckenstein	NULL
,	NULL
K.	NULL
McGuire	NULL
,	NULL
M.-C.	NULL
Dokhelar	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
and	NULL
W.	NULL
Haseltine	NULL
.	NULL

1989	NULL
.	NULL

Transformation	NULL
to	NULL
continuous	NULL
growth	NULL
of	NULL
primary	NULL
human	NULL
T-lymphocytes	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
X-region	NULL
genes	NULL
transduced	NULL
by	NULL
Herpesvirus	NULL
saimiri	NULL
vector	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
86:3351-3355	NULL
.	NULL

Greene	NULL
,	NULL
W.	NULL
C.	NULL
,	NULL
W.	NULL
J.	NULL
Leonard	NULL
,	NULL
Y.	NULL
Wano	NULL
,	NULL
P.	NULL
B.	NULL
Svetlik	NULL
,	NULL
N.	NULL
J.	NULL
Peffer	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
W.	NULL
C.	NULL
Gob	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1986	NULL
.	NULL

Transactivator	NULL
gene	NULL
of	NULL
HTLV-II	NULL
induces	NULL
IL-2	NULL
receptor	NULL
and	NULL
IL-2	NULL
cellular	NULL
gene	NULL
expression	NULL
.	NULL

Science	NULL
232:877	NULL
.	NULL

Grossman	NULL
,	NULL
W.	NULL
J.	NULL
,	NULL
J.	NULL
T.	NULL
Kimata	NULL
,	NULL
F.	NULL
H.	NULL
Wong	NULL
,	NULL
M.	NULL
Zutter	NULL
,	NULL
T.	NULL
J.	NULL
Ley	NULL
,	NULL
and	NULL
L.	NULL
Ratner	NULL
.	NULL

1995	NULL
.	NULL

Development	NULL
of	NULL
leukemia	NULL
in	NULL
mice	NULL
transgenic	NULL
for	NULL
the	NULL
tax	NULL
gene	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
92:1057-1061	NULL
.	NULL

Himes	NULL
,	NULL
S.	NULL
R.	NULL
,	NULL
L.	NULL
S.	NULL
Coles	NULL
,	NULL
R.	NULL
Katsikeros	NULL
,	NULL
R.	NULL
K.	NULL
Lang	NULL
,	NULL
and	NULL
M.	NULL
F.	NULL
Shannon	NULL
.	NULL

1993	NULL
.	NULL

HTLV-I	NULL
tax	NULL
activation	NULL
of	NULL
the	NULL
GM-CSF	NULL
and	NULL
G-CSF	NULL
promoters	NULL
requires	NULL
the	NULL
interaction	NULL
of	NULL
NF-kappa	NULL
B	NULL
with	NULL
other	NULL
transcription	NULL
factor	NULL
fam-ilies	NULL
.	NULL

Oncogene	NULL
8:3189-3197	NULL
.	NULL

Hirai	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
Fujisawa	NULL
,	NULL
K.	NULL
Suzuki	NULL
,	NULL
M.	NULL
Ueda	NULL
,	NULL
M.	NULL
Muramatsu	NULL
,	NULL
A.	NULL
Tsuboi	NULL
,	NULL
N.	NULL
Arai	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1992	NULL
.	NULL

Transcriptional	NULL
activator	NULL
Tax	NULL
of	NULL
HTLV-1	NULL
binds	NULL
to	NULL
the	NULL
NF-kB	NULL
precursor	NULL
p105	NULL
.	NULL

Oncogene	NULL
7:1737-1742	NULL
.	NULL

Hori	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
M.	NULL
Carey	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
role	NULL
of	NULL
activators	NULL
in	NULL
assembly	NULL
of	NULL
RNA	NULL
polymerase	NULL
II	NULL
transcription	NULL
complexes	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

4:236-244	NULL
.	NULL

Ikeuchi	NULL
,	NULL
K.	NULL
,	NULL
S.	NULL
Kim	NULL
,	NULL
R.	NULL
Byrn	NULL
,	NULL
S.	NULL
Goldring	NULL
,	NULL
and	NULL
J.	NULL
Groopman	NULL
.	NULL

1990	NULL
.	NULL

Infection	NULL
of	NULL
nonlymphoid	NULL
cells	NULL
by	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
or	NULL
type	NULL
2	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:4226-4231	NULL
.	NULL

Ingles	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
M.	NULL
Shales	NULL
,	NULL
W.	NULL
D.	NULL
Cress	NULL
,	NULL
S.	NULL
J.	NULL
Triezenberg	NULL
,	NULL
and	NULL
J.	NULL
Greenblatt	NULL
.	NULL

1991	NULL
.	NULL

Reduced	NULL
binding	NULL
of	NULL
TFIID	NULL
to	NULL
transcriptionally	NULL
compromised	NULL
mutants	NULL
of	NULL
VP16	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
351:588-590	NULL
.	NULL

Inostroza	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
,	NULL
F.	NULL
H.	NULL
Mermelstein	NULL
,	NULL
I.	NULL
Ha	NULL
,	NULL
W.	NULL
S.	NULL
Lane	NULL
,	NULL
and	NULL
D.	NULL
Reinberg	NULL
.	NULL

1992	NULL
.	NULL

Dri	NULL
,	NULL
a	NULL
TATA-binding	NULL
protein-associated	NULL
phosphoprotein	NULL
and	NULL
inhibitor	NULL
of	NULL
class	NULL
II	NULL
gene	NULL
transcription	NULL
.	NULL

Cell	NULL
70:477-489	NULL
.	NULL

Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

57	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

65	NULL
.	NULL

66	NULL
.	NULL

67	NULL
.	NULL

68	NULL
.	NULL

Inoue	NULL
,	NULL
J.	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
T.	NULL
Taniguchi	NULL
,	NULL
S.	NULL
Tsuru	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1986	NULL
.	NULL

Induction	NULL
of	NULL
interleukin	NULL
2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
p40	NULL
``	NULL
encoded	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

5:2883-2888	NULL
.	NULL

Jeang	NULL
,	NULL
K.-T.	NULL
,	NULL
J.	NULL
Brady	NULL
,	NULL
M.	NULL
Radonovich	NULL
,	NULL
J.	NULL
Duvall	NULL
,	NULL
and	NULL
G.	NULL
Khoury	NULL
.	NULL

1988.	NULL
p40	NULL
``	NULL
*	NULL
frans-activation	NULL
of	NULL
the	NULL
HTLV-1	NULL
LTR	NULL
promoter	NULL
,	NULL
p.	NULL
181-189	NULL
.	NULL

In	NULL
B.	NULL
Cullen	NULL
,	NULL
L.	NULL
P.	NULL
Gage	NULL
,	NULL
M.	NULL
A.	NULL
Q.	NULL
Siddiqi	NULL
,	NULL
A.	NULL
M.	NULL
Skalka	NULL
,	NULL
and	NULL
H.	NULL
Weissbach	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Mechanisms	NULL
of	NULL
control	NULL
of	NULL
gene	NULL
expression	NULL
.	NULL

Alan	NULL
R.	NULL
Liss	NULL
,	NULL
Inc.	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Kang	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
D.	NULL
T.	NULL
Auble	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Ranish	NULL
,	NULL
and	NULL
S.	NULL
Hahn	NULL
.	NULL

1995	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
yeast	NULL
transcription	NULL
factor	NULL
TFIIA	NULL
:	NULL
distinct	NULL
functional	NULL
regions	NULL
and	NULL
polymerase	NULL
II-specific	NULL
role	NULL
in	NULL
basal	NULL
and	NULL
activated	NULL
transcription	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15	NULL
:	NULL
1234-1243	NULL
.	NULL

Kanno	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Brown	NULL
,	NULL
and	NULL
U.	NULL
Siebenlist	NULL
.	NULL

1995	NULL
.	NULL

Evidence	NULL
in	NULL
support	NULL
of	NULL
a	NULL
role	NULL
for	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
Tax	NULL
in	NULL
activating	NULL
NF-kappa	NULL
B	NULL
via	NULL
stimulation	NULL
of	NULL
signaling	NULL
pathways	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:11745-11748	NULL
.	NULL

Kashanchi	NULL
,	NULL
F.	NULL
,	NULL
J.	NULL
F.	NULL
Duvall	NULL
,	NULL
and	NULL
J.	NULL
N.	NULL
Brady	NULL
.	NULL

1992	NULL
.	NULL

Electroporation	NULL
of	NULL
viral	NULL
transactivator	NULL
proteins	NULL
into	NULL
lymphocyte	NULL
suspension	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
.	NULL

20:4673-4674	NULL
.	NULL

Kim	NULL
,	NULL
T.	NULL
K.	NULL
,	NULL
Y.	NULL
Zhao	NULL
,	NULL
H.	NULL
Ge	NULL
,	NULL
R.	NULL
Bernstein	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1995	NULL
.	NULL

TATA-binding	NULL
protein	NULL
residues	NULL
implicated	NULL
in	NULL
a	NULL
functional	NULL
interplay	NULL
between	NULL
negative	NULL
cofactor	NULL
NC2	NULL
(	NULL
Dr1	NULL
)	NULL
and	NULL
general	NULL
transcription	NULL
factors	NULL
TFIIA	NULL
and	NULL
TFIIB	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:10976-10981	NULL
.	NULL

Kobayashi	NULL
,	NULL
N.	NULL
,	NULL
T.	NULL
G.	NULL
Boyer	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
Berk	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
class	NULL
of	NULL
activation	NULL
domains	NULL
interacts	NULL
directly	NULL
with	NULL
TFIIA	NULL
and	NULL
stimulates	NULL
TFIIA-TFIID-pro-moter	NULL
complex	NULL
assembly	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:6465-6473	NULL
.	NULL

Kraus	NULL
,	NULL
V.	NULL
B.	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Inostroza	NULL
,	NULL
K.	NULL
Yeung	NULL
,	NULL
D.	NULL
Reinberg	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Nevins	NULL
.	NULL

1994	NULL
.	NULL

Interaction	NULL
of	NULL
the	NULL
Dr-1	NULL
inhibitory	NULL
factor	NULL
with	NULL
the	NULL
TATA	NULL
binding	NULL
protein	NULL
is	NULL
disrupted	NULL
by	NULL
adenovirus	NULL
E1A	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:6279-6282	NULL
.	NULL

Lanoix	NULL
,	NULL
J.	NULL
,	NULL
J.	NULL
Lacoste	NULL
,	NULL
N.	NULL
Pepin	NULL
,	NULL
N.	NULL
Rice	NULL
,	NULL
and	NULL
J.	NULL
Hiscott	NULL
.	NULL

1994	NULL
.	NULL

Overproduction	NULL
of	NULL
NFKB2	NULL
(	NULL
lyt-10	NULL
)	NULL
and	NULL
c-Rel	NULL
:	NULL
a	NULL
mechanism	NULL
for	NULL
HTLV-1	NULL
Tax-mediated	NULL
trans-activation	NULL
via	NULL
the	NULL
NF-kappa	NULL
B	NULL
signalling	NULL
pathway	NULL
.	NULL

Oncogene	NULL
9:841-852	NULL
.	NULL

Leung	NULL
,	NULL
K.	NULL
,	NULL
and	NULL
G.	NULL
J.	NULL
Nabel	NULL
.	NULL

1988	NULL
.	NULL

HTLV-1	NULL
transactivator	NULL
induces	NULL
interleukin-2	NULL
receptor	NULL
expression	NULL
through	NULL
an	NULL
NF-kB-like	NULL
factor	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
333:776-778	NULL
.	NULL

Lieberman	NULL
,	NULL
P.	NULL
M.	NULL
,	NULL
and	NULL
A.	NULL
J.	NULL
Berk	NULL
.	NULL

1994	NULL
.	NULL

A	NULL
mechanism	NULL
for	NULL
TAFs	NULL
in	NULL
transcriptional	NULL
activation	NULL
:	NULL
activation	NULL
domain	NULL
enhancement	NULL
of	NULL
TFIID-TFIIA-promoter	NULL
DNA	NULL
complex	NULL
formation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:995-1006	NULL
.	NULL

Lin	NULL
,	NULL
Y.	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1991	NULL
.	NULL

Mechanism	NULL
of	NULL
action	NULL
of	NULL
an	NULL
acidic	NULL
transcriptional	NULL
activator	NULL
in	NULL
vitro	NULL
.	NULL

Cell	NULL
64:971-981	NULL
.	NULL

Ma	NULL
,	NULL
D.	NULL
,	NULL
H.	NULL
Watanabe	NULL
,	NULL
F.	NULL
Mermelstein	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
K.	NULL
Oguri	NULL
,	NULL
X	NULL
.	NULL

Sun	NULL
,	NULL
T.	NULL
Wada	NULL
,	NULL
T.	NULL
Imai	NULL
,	NULL
T.	NULL
Shiroya	NULL
,	NULL
D.	NULL
Reinberg	NULL
,	NULL
and	NULL
H.	NULL
Handa	NULL
.	NULL

1993	NULL
.	NULL

Isolation	NULL
of	NULL
a	NULL
cDNA	NULL
encoding	NULL
the	NULL
largest	NULL
subunit	NULL
of	NULL
TFIIA	NULL
reveals	NULL
functions	NULL
important	NULL
for	NULL
activated	NULL
transcription	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2246-2257	NULL
.	NULL

Maggirwar	NULL
,	NULL
S.	NULL
B.	NULL
,	NULL
E.	NULL
Harhaj	NULL
,	NULL
and	NULL
S.	NULL
C.	NULL
Sun	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
NF-kappa	NULL
B/Rel	NULL
by	NULL
Tax	NULL
involves	NULL
degradation	NULL
of	NULL
I	NULL
kappa	NULL
B-alpha	NULL
and	NULL
is	NULL
blocked	NULL
by	NULL
a	NULL
proteasome	NULL
inhibitor	NULL
.	NULL

Oncogene	NULL
11:993-998	NULL
.	NULL

Manley	NULL
,	NULL
J.	NULL
L.	NULL
,	NULL
A	NULL
.	NULL

Fire	NULL
,	NULL
A.	NULL
Cano	NULL
,	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
,	NULL
and	NULL
M.	NULL
L.	NULL
Gefter	NULL
.	NULL

1980	NULL
.	NULL

DNA-dependent	NULL
transcription	NULL
of	NULL
adenovirus	NULL
genes	NULL
in	NULL
a	NULL
soluble	NULL
whole-cell	NULL
extract	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
77:3855-3859	NULL
.	NULL

Meisterernst	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1991	NULL
.	NULL

Family	NULL
of	NULL
proteins	NULL
that	NULL
interact	NULL
with	NULL
TFIID	NULL
and	NULL
regulate	NULL
promoter	NULL
activity	NULL
.	NULL

Cell	NULL
67:557-567	NULL
.	NULL

Merino	NULL
,	NULL
A.	NULL
,	NULL
K.	NULL
R.	NULL
Madden	NULL
,	NULL
W.	NULL
S.	NULL
Lane	NULL
,	NULL
J.	NULL
J.	NULL
Champoux	NULL
,	NULL
and	NULL
D.	NULL
Reinberg	NULL
.	NULL

1993	NULL
.	NULL

DNA	NULL
topoisomerase	NULL
I	NULL
is	NULL
involved	NULL
in	NULL
both	NULL
repression	NULL
and	NULL
activation	NULL
of	NULL
transcription	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
365:227-232	NULL
.	NULL

Mori	NULL
,	NULL
N.	NULL
,	NULL
S.	NULL
Murakami	NULL
,	NULL
S.	NULL
Oda	NULL
,	NULL
D.	NULL
Prager	NULL
,	NULL
and	NULL
S.	NULL
Eto	NULL
.	NULL

1995	NULL
.	NULL

Production	NULL
of	NULL
interleukin	NULL
8	NULL
in	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
cells	NULL
:	NULL
possible	NULL
transactivation	NULL
of	NULL
the	NULL
interleukin	NULL
8	NULL
gene	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
Tax	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

55:3592-3597	NULL
.	NULL

Mori	NULL
,	NULL
N.	NULL
,	NULL
F.	NULL
Shirakawa	NULL
,	NULL
K.	NULL
Saito	NULL
,	NULL
S.	NULL
Murakami	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1994	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
interleukin-1	NULL
alpha	NULL
gene	NULL
promoter	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
tax	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Blood	NULL
84:1688-1689	NULL
.	NULL

Murakami	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Hirai	NULL
,	NULL
T.	NULL
Suzuki	NULL
,	NULL
J.	NULL
Fujisawa	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1995	NULL
.	NULL

HTLV-I	NULL
Tax	NULL
enhances	NULL
NF-kappa	NULL
B2	NULL
expression	NULL
and	NULL
binds	NULL
to	NULL
the	NULL
products	NULL
p52	NULL
and	NULL
p100	NULL
,	NULL
but	NULL
does	NULL
not	NULL
suppress	NULL
the	NULL
inhibitory	NULL
function	NULL
of	NULL
p100	NULL
.	NULL

Virology	NULL
206:1066-1074	NULL
.	NULL

Nakajima	NULL
,	NULL
N.	NULL
,	NULL
M.	NULL
Horikoshi	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1988	NULL
.	NULL

Factors	NULL
involved	NULL
in	NULL
specific	NULL
transcription	NULL
by	NULL
mammalian	NULL
RNA	NULL
polymerase	NULL
II	NULL
:	NULL
purification	NULL
,	NULL
genetic	NULL
specificity	NULL
,	NULL
and	NULL
TATA	NULL
box-promoter	NULL
interactions	NULL
of	NULL
TFIID	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

8:4028-4040	NULL
.	NULL

Nelson	NULL
,	NULL
H.	NULL
1995	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
DNA-binding	NULL
proteins	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

5:180-189	NULL
.	NULL

Nimer	NULL
,	NULL
S.	NULL
D.	NULL
,	NULL
J.	NULL
C.	NULL
Gasson	NULL
,	NULL
K.	NULL
Hu	NULL
,	NULL
I.	NULL
Smalberg	NULL
,	NULL
J.	NULL
L.	NULL
Williams	NULL
,	NULL
I.	NULL
S.	NULL
Y.	NULL
Chen	NULL
,	NULL
and	NULL
J.	NULL
D.	NULL
Rosenblatt	NULL
.	NULL

1989	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
by	NULL
HTLV-I	NULL
and	NULL
-II	NULL
tax	NULL
proteins	NULL
.	NULL

Oncogene	NULL
4:671	NULL
.	NULL

Osame	NULL
,	NULL
M.	NULL
,	NULL
K.	NULL
Usuku	NULL
,	NULL
S.	NULL
Izumo	NULL
,	NULL
N.	NULL
Tjichi	NULL
,	NULL
H.	NULL
Amitani	NULL
,	NULL
A.	NULL
Igata	NULL
,	NULL
M.	NULL
Mat-sumoto	NULL
,	NULL
and	NULL
M.	NULL
Tara	NULL
.	NULL

1986	NULL
.	NULL

HTLV-I	NULL
associated	NULL
myelopathy	NULL
,	NULL
a	NULL
new	NULL
clinical	NULL
entity	NULL
.	NULL

Lancet	NULL
ii1031-1032	NULL
.	NULL

Ozer	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
A.	NULL
Moore	NULL
,	NULL
A.	NULL
H.	NULL
Bolden	NULL
,	NULL
A.	NULL
Lee	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
P.	NULL
M.	NULL
Lieberman	NULL
.	NULL

1994	NULL
.	NULL

Molecular	NULL
cloning	NULL
of	NULL
the	NULL
small	NULL
(	NULL
gamma	NULL
)	NULL
subunit	NULL
of	NULL
human	NULL
TFIIA	NULL
reveals	NULL
functions	NULL
critical	NULL
for	NULL
activated	NULL
transcription	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:2324-2335	NULL
.	NULL

Paskalis	NULL
,	NULL
H.	NULL
,	NULL
B.	NULL
K.	NULL
Felber	NULL
,	NULL
and	NULL
G.	NULL
N.	NULL
Pavlakis	NULL
.	NULL

1986	NULL
.	NULL

Cis-acting	NULL
sequences	NULL
HTLV-1	NULL
Tax	NULL
TRANSACTIVATOR	NULL
INTERACTION	NULL
WITH	NULL
TFIIA	NULL
69	NULL
.	NULL

70	NULL
.	NULL

71	NULL
.	NULL

72	NULL
.	NULL

73	NULL
.	NULL

74	NULL
.	NULL

75	NULL
.	NULL

76	NULL
.	NULL

77	NULL
.	NULL

78	NULL
.	NULL

79	NULL
.	NULL

80	NULL
.	NULL

81	NULL
.	NULL

82	NULL
.	NULL

83	NULL
.	NULL

84	NULL
.	NULL

85	NULL
.	NULL

86	NULL
.	NULL

87	NULL
.	NULL

88	NULL
.	NULL

89	NULL
.	NULL

90	NULL
.	NULL

91	NULL
.	NULL

92	NULL
.	NULL

93	NULL
.	NULL

4663	NULL
responsible	NULL
for	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
constitute	NULL
a	NULL
conditional	NULL
enhancer	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
83:6558-6562	NULL
.	NULL

Paul	NULL
,	NULL
N.	NULL
L.	NULL
,	NULL
M.	NULL
J.	NULL
Lenardo	NULL
,	NULL
K.	NULL
D.	NULL
Novak	NULL
,	NULL
T.	NULL
Sarr	NULL
,	NULL
W.-L.	NULL
Tang	NULL
,	NULL
and	NULL
N.	NULL
H.	NULL
Ruddle	NULL
.	NULL

1990	NULL
.	NULL

Lymphotoxin	NULL
activation	NULL
by	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
T-infected	NULL
cell	NULL
lines	NULL
:	NULL
role	NULL
for	NULL
NF-kB	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:5412-5419	NULL
.	NULL

Paul	NULL
,	NULL
N.	NULL
L.	NULL
,	NULL
I.	NULL
Millet	NULL
,	NULL
and	NULL
N.	NULL
H.	NULL
Ruddle	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
lymphotoxin	NULL
promoter	NULL
is	NULL
stimulated	NULL
by	NULL
HTLV-I	NULL
tax	NULL
activation	NULL
of	NULL
NF-kappa	NULL
B	NULL
in	NULL
human	NULL
T-cell	NULL
lines	NULL
.	NULL

Cytokine	NULL
5:372-378	NULL
.	NULL

Perini	NULL
,	NULL
G.	NULL
,	NULL
S.	NULL
Wagner	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1995	NULL
.	NULL

Recognition	NULL
of	NULL
bZIP	NULL
proteins	NULL
by	NULL
the	NULL
human	NULL
T-cell	NULL
leukaemia	NULL
virus	NULL
transactivator	NULL
Tax	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
376:602-605	NULL
.	NULL

Poiesz	NULL
,	NULL
B.	NULL
,	NULL
F.	NULL
Ruscetti	NULL
,	NULL
A.	NULL
Gazdar	NULL
,	NULL
P.	NULL
Bunn	NULL
,	NULL
J.	NULL
Minna	NULL
,	NULL
and	NULL
R.	NULL
Gallo	NULL
.	NULL

1980	NULL
.	NULL

Detection	NULL
and	NULL
isolation	NULL
of	NULL
type	NULL
C	NULL
retrovirus	NULL
particles	NULL
from	NULL
fresh	NULL
and	NULL
cultured	NULL
lymphocytes	NULL
of	NULL
a	NULL
patient	NULL
with	NULL
cutaneous	NULL
T-cell	NULL
lymphoma	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
77:7415-7419	NULL
.	NULL

Reinberg	NULL
,	NULL
D.	NULL
,	NULL
M.	NULL
Horikoshi	NULL
,	NULL
and	NULL
R.	NULL
G.	NULL
Roeder	NULL
.	NULL

1987	NULL
.	NULL

Factors	NULL
involved	NULL
in	NULL
specific	NULL
transcription	NULL
in	NULL
mammalian	NULL
RNA	NULL
polymerase	NULL
II	NULL
:	NULL
functional	NULL
analysis	NULL
of	NULL
initiation	NULL
factors	NULL
IIA	NULL
and	NULL
IID	NULL
and	NULL
identification	NULL
of	NULL
a	NULL
new	NULL
factor	NULL
operating	NULL
at	NULL
sequences	NULL
downstream	NULL
of	NULL
the	NULL
initiator	NULL
site	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

262:3322-3330	NULL
.	NULL

Reynolds	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
V.	NULL
Lundblad	NULL
.	NULL

1989	NULL
.	NULL

Yeast	NULL
vectors	NULL
and	NULL
assays	NULL
for	NULL
the	NULL
expression	NULL
of	NULL
cloned	NULL
genes	NULL
,	NULL
p.	NULL
13.6.1-13.6.4	NULL
.	NULL

In	NULL
F.	NULL
A.	NULL
Ausubel	NULL
,	NULL
R.	NULL
Brent	NULL
,	NULL
D.	NULL
D.	NULL
Kingston	NULL
,	NULL
J.	NULL
G.	NULL
Moore	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Seidman	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Smith	NULL
,	NULL
and	NULL
K.	NULL
Struhl	NULL
(	NULL
ed	NULL
.	NULL
)	NULL

,	NULL
Current	NULL
protocols	NULL
in	NULL
molecular	NULL
biology	NULL
.	NULL

Greene	NULL
Publishing	NULL
Associates	NULL
and	NULL
Wiley-Interscience	NULL
,	NULL
New	NULL
York	NULL
.	NULL

Rosen	NULL
,	NULL
C.	NULL
A.	NULL
,	NULL
J.	NULL
G.	NULL
Sodroski	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1985	NULL
.	NULL

Location	NULL
of	NULL
cis-acting	NULL
regulatory	NULL
sequences	NULL
in	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
long	NULL
terminal	NULL
repeat	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
82:6502-6506	NULL
.	NULL

Ruben	NULL
,	NULL
S.	NULL
,	NULL
H.	NULL
Poteat	NULL
,	NULL
T.-H.	NULL
Tan	NULL
,	NULL
K.	NULL
Kawakami	NULL
,	NULL
R.	NULL
Roeder	NULL
,	NULL
W.	NULL
Haseltine	NULL
,	NULL
and	NULL
C.	NULL
A.	NULL
Rosen	NULL
.	NULL

1988	NULL
.	NULL

Cellular	NULL
transcription	NULL
factors	NULL
and	NULL
regulation	NULL
of	NULL
IL-2	NULL
receptor	NULL
gene	NULL
expression	NULL
by	NULL
HTLV-I	NULL
tax	NULL
gene	NULL
product	NULL
.	NULL

Science	NULL
241:89-92	NULL
.	NULL

Sawada	NULL
,	NULL
M.	NULL
,	NULL
A.	NULL
Suzumura	NULL
,	NULL
M.	NULL
Yoshida	NULL
,	NULL
and	NULL
T.	NULL
Marunouchi	NULL
.	NULL

1990	NULL
.	NULL

Human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
trans-activator	NULL
induces	NULL
class	NULL
I	NULL
major	NULL
histocompatibility	NULL
complex	NULL
antigen	NULL
expression	NULL
in	NULL
glial	NULL
cells	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

64:4002-4006	NULL
.	NULL

Schneider	NULL
,	NULL
U.	NULL
,	NULL
J.-U	NULL
.	NULL

Schwenk	NULL
,	NULL
and	NULL
G.	NULL
Bonkamm	NULL
.	NULL

1977	NULL
.	NULL

Characterization	NULL
of	NULL
EBV-genome	NULL
negative	NULL
``	NULL
null	NULL
``	NULL
and	NULL
``	NULL
T	NULL
``	NULL
cell	NULL
lines	NULL
derived	NULL
from	NULL
children	NULL
with	NULL
acute	NULL
lymphoblastic	NULL
leukemia	NULL
and	NULL
leukemia	NULL
transformed	NULL
non-Hodgkin	NULL
lymphoma	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
19:621-626	NULL
.	NULL

Semmes	NULL
,	NULL
O.	NULL
J.	NULL
,	NULL
and	NULL
K.	NULL
Jeang	NULL
.	NULL

1995	NULL
.	NULL

Definition	NULL
of	NULL
a	NULL
minimal	NULL
activation	NULL
domain	NULL
in	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:1827-1833	NULL
.	NULL

Semmes	NULL
,	NULL
O.	NULL
J.	NULL
,	NULL
and	NULL
K.	NULL
T.	NULL
Jeang	NULL
.	NULL

1992	NULL
.	NULL

Mutational	NULL
analysis	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
:	NULL
regions	NULL
necessary	NULL
for	NULL
function	NULL
determined	NULL
with	NULL
47	NULL
mutant	NULL
proteins	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

66:7183-7192	NULL
.	NULL

Sheldon	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
D.	NULL
Reinberg	NULL
.	NULL

1995	NULL
.	NULL

Tuning-up	NULL
transcription	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

5143-46	NULL
.	NULL

Shykind	NULL
,	NULL
B.	NULL
M.	NULL
,	NULL
J.	NULL
Kim	NULL
,	NULL
and	NULL
P.	NULL
A	NULL
.	NULL

Sharp	NULL
.	NULL

1995	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
TFIID-TFIIA	NULL
complex	NULL
with	NULL
HMG-2	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

9:1354-1365	NULL
.	NULL

Sickevitz	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
B.	NULL
Feinberg	NULL
,	NULL
N.	NULL
Holbrook	NULL
,	NULL
F.	NULL
Wong-Staal	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1987	NULL
.	NULL

Activation	NULL
of	NULL
interleukin	NULL
2	NULL
and	NULL
interleukin	NULL
2	NULL
receptor	NULL
(	NULL
Tac	NULL
)	NULL
promoter	NULL
expression	NULL
by	NULL
the	NULL
trans-activator	NULL
(	NULL
tat	NULL
)	NULL
gene	NULL
product	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
,	NULL
type	NULL
I.	NULL
Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
84:5389-5393	NULL
.	NULL

Smith	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
and	NULL
W.	NULL
C.	NULL
Greene	NULL
.	NULL

1990	NULL
.	NULL

Identification	NULL
of	NULL
HTLV-I	NULL
fax	NULL
transactivator	NULL
mutants	NULL
exhibiting	NULL
novel	NULL
transcriptional	NULL
phenotypes	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

4:1875-1885	NULL
.	NULL

Sodroski	NULL
,	NULL
J.	NULL
G.	NULL
,	NULL
C.	NULL
A.	NULL
Rosen	NULL
,	NULL
and	NULL
W.	NULL
A.	NULL
Haseltine	NULL
.	NULL

1984	NULL
.	NULL

Trans-acting	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
long	NULL
terminal	NULL
repeat	NULL
of	NULL
human	NULL
T	NULL
lymphotropic	NULL
viruses	NULL
in	NULL
infected	NULL
cells	NULL
.	NULL

Science	NULL
225:381-385	NULL
.	NULL

Stringer	NULL
,	NULL
K.	NULL
F.	NULL
,	NULL
C.	NULL
J.	NULL
Ingles	NULL
,	NULL
and	NULL
J.	NULL
Greenblatt	NULL
.	NULL

1990	NULL
.	NULL

Direct	NULL
and	NULL
selective	NULL
binding	NULL
of	NULL
an	NULL
acidic	NULL
transcriptional	NULL
activation	NULL
domain	NULL
to	NULL
the	NULL
TATA-box	NULL
factor	NULL
TFIID	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
345:783-786	NULL
.	NULL

Sun	NULL
,	NULL
X.	NULL
,	NULL
D.	NULL
Ma	NULL
,	NULL
M.	NULL
Sheldon	NULL
,	NULL
K.	NULL
Yeung	NULL
,	NULL
and	NULL
D.	NULL
Reinberg	NULL
.	NULL

1994	NULL
.	NULL

Reconsti-tution	NULL
of	NULL
human	NULL
TFIIA	NULL
activity	NULL
from	NULL
recombinant	NULL
polypeptides	NULL
:	NULL
a	NULL
role	NULL
in	NULL
TFIID-mediated	NULL
transcription	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:2336-2348	NULL
.	NULL

Suzuki	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Hirai	NULL
,	NULL
T.	NULL
Murakami	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1995	NULL
.	NULL

Tax	NULL
protein	NULL
of	NULL
HTLV-1	NULL
destabilizes	NULL
the	NULL
complexes	NULL
of	NULL
NF-kappa	NULL
B	NULL
and	NULL
I	NULL
kappa	NULL
B-alpha	NULL
and	NULL
induces	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kappa	NULL
B	NULL
for	NULL
transcriptional	NULL
activation	NULL
.	NULL

Oncogene	NULL
10:1199-1207	NULL
.	NULL

Suzuki	NULL
,	NULL
T.	NULL
,	NULL
H.	NULL
Hirai	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1994	NULL
.	NULL

Tax	NULL
protein	NULL
of	NULL
HTLV-I	NULL
interacts	NULL
with	NULL
the	NULL
Rel	NULL
homology	NULL
domain	NULL
of	NULL
NF-kappa	NULL
B	NULL
p65	NULL
and	NULL
c-Rel	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
NF-kappa	NULL
B	NULL
binding	NULL
site	NULL
and	NULL
activates	NULL
transcription	NULL
.	NULL

Oncogene	NULL
9:3099-3105	NULL
.	NULL

Tanaka	NULL
,	NULL
A.	NULL
,	NULL
C.	NULL
Takahashi	NULL
,	NULL
S.	NULL
Yamaoka	NULL
,	NULL
T.	NULL
Nosaka	NULL
,	NULL
M.	NULL
Maki	NULL
,	NULL
and	NULL
M.	NULL
Hatanaka	NULL
.	NULL

1990	NULL
.	NULL

Oncogenic	NULL
transformation	NULL
by	NULL
the	NULL
tax	NULL
gene	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
I	NULL
in	NULL
vitro	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:1071-1075	NULL
.	NULL

Thut	NULL
,	NULL
C.	NULL
J.	NULL
,	NULL
J.	NULL
L.	NULL
Chen	NULL
,	NULL
R.	NULL
Klemm	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1995.	NULL
p53	NULL
transcriptional	NULL
activation	NULL
mediated	NULL
by	NULL
coactivators	NULL
TAFp40	NULL
and	NULL
TAF	NULL
,	NULL
,60	NULL
.	NULL

Science	NULL
267	NULL
:	NULL
100-104	NULL
.	NULL

Triezenberg	NULL
,	NULL
S.	NULL
1995	NULL
.	NULL

Structure	NULL
and	NULL
function	NULL
of	NULL
transcriptional	NULL
activation	NULL
domains	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Genet	NULL
.	NULL

Dev	NULL
.	NULL

5:190-196	NULL
.	NULL

Tsuchiya	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Fujii	NULL
,	NULL
Y.	NULL
Tanaka	NULL
,	NULL
H.	NULL
Tozawa	NULL
,	NULL
and	NULL
M.	NULL
Seiki	NULL
.	NULL

1994	NULL
.	NULL

Two	NULL
4664	NULL
94	NULL
.	NULL

95	NULL
.	NULL

96	NULL
.	NULL

97	NULL
.	NULL

98	NULL
.	NULL

99	NULL
.	NULL

100	NULL
.	NULL

101	NULL
.	NULL

102	NULL
.	NULL

103	NULL
.	NULL

CLEMENS	NULL
ET	NULL
AL	NULL
.	NULL

distinct	NULL
regions	NULL
form	NULL
a	NULL
functional	NULL
activation	NULL
domain	NULL
of	NULL
the	NULL
HTLV-1	NULL
transactivator	NULL
Tax1	NULL
.	NULL

Oncogene	NULL
9:337-340	NULL
.	NULL

Van	NULL
Dyke	NULL
,	NULL
M.	NULL
,	NULL
R.	NULL
G.	NULL
Roeder	NULL
,	NULL
and	NULL
M.	NULL
Sawadogo	NULL
.	NULL

1988	NULL
.	NULL

Physical	NULL
analysis	NULL
of	NULL
transcription	NULL
preinitiation	NULL
complex	NULL
assembly	NULL
on	NULL
a	NULL
class	NULL
II	NULL
gene	NULL
promoter	NULL
.	NULL

Science	NULL
241:1335-1338	NULL
.	NULL

Verrijzer	NULL
,	NULL
C.	NULL
P.	NULL
,	NULL
J.-L.	NULL
Chen	NULL
,	NULL
K.	NULL
Yokomori	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1995	NULL
.	NULL

Binding	NULL
of	NULL
TAFs	NULL
to	NULL
core	NULL
elements	NULL
directs	NULL
promoter	NULL
selectivity	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
.	NULL

Cell	NULL
81:1115-1125	NULL
.	NULL

Wagner	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
M.	NULL
Green	NULL
.	NULL

1993	NULL
.	NULL

HTLV-I	NULL
Tax	NULL
protein	NULL
stimulation	NULL
of	NULL
DNA	NULL
binding	NULL
of	NULL
bZIP	NULL
proteins	NULL
by	NULL
enhancing	NULL
dimerization	NULL
.	NULL

Science	NULL
262:395-399	NULL
.	NULL

Wang	NULL
,	NULL
W.	NULL
,	NULL
J.	NULL
D.	NULL
Gralla	NULL
,	NULL
and	NULL
M.	NULL
Carey	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
acidic	NULL
activator	NULL
GAL4-AH	NULL
can	NULL
stimulate	NULL
polymerase	NULL
II	NULL
transcription	NULL
by	NULL
promoting	NULL
assembly	NULL
of	NULL
a	NULL
closed	NULL
complex	NULL
requiring	NULL
TFIID	NULL
and	NULL
TFIIA	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:1716-1727	NULL
.	NULL

Watanabe	NULL
,	NULL
T.	NULL
,	NULL
K.	NULL
Yamaguchi	NULL
,	NULL
K.	NULL
Takatsuki	NULL
,	NULL
M.	NULL
Osame	NULL
,	NULL
and	NULL
M.	NULL
Yoshida	NULL
.	NULL

1990	NULL
.	NULL

Constitutive	NULL
expression	NULL
of	NULL
parathyroid	NULL
hormone-related	NULL
protein	NULL
gene	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
carriers	NULL
and	NULL
adult	NULL
T	NULL
cell	NULL
leukemia	NULL
patients	NULL
that	NULL
can	NULL
be	NULL
frens-activated	NULL
by	NULL
HTLV-1	NULL
tax	NULL
gene	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172:759-765	NULL
.	NULL

White	NULL
,	NULL
R.	NULL
J.	NULL
,	NULL
B.	NULL
C.	NULL
Khoo	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Inostroza	NULL
,	NULL
D.	NULL
Reinberg	NULL
,	NULL
and	NULL
S.	NULL
P.	NULL
Jackson	NULL
.	NULL

1994	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
RNA	NULL
polymerases	NULL
I	NULL
,	NULL
II	NULL
,	NULL
and	NULL
III	NULL
by	NULL
the	NULL
TBP-binding	NULL
repressor	NULL
Dr1	NULL
.	NULL

Science	NULL
266:448-450	NULL
.	NULL

Wolin	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Kornuc	NULL
,	NULL
C.	NULL
Hong	NULL
,	NULL
S.	NULL
K.	NULL
Shin	NULL
,	NULL
F.	NULL
Lee	NULL
,	NULL
R.	NULL
Lau	NULL
,	NULL
and	NULL
S.	NULL
Nimer	NULL
.	NULL

1993	NULL
.	NULL

Differential	NULL
effect	NULL
of	NULL
HTLV-I	NULL
infection	NULL
and	NULL
HTVL	NULL
Tax	NULL
on	NULL
interleukin	NULL
3	NULL
expression	NULL
.	NULL

Oncogene	NULL
8:1905-1911	NULL
.	NULL

Xiao	NULL
,	NULL
H.	NULL
,	NULL
A.	NULL
Pearson	NULL
,	NULL
B.	NULL
Coulombe	NULL
,	NULL
R.	NULL
Truat	NULL
,	NULL
S.	NULL
Zhang	NULL
,	NULL
J.	NULL
L.	NULL
Regier	NULL
,	NULL
S.	NULL
L.	NULL
Triezenberg	NULL
,	NULL
D.	NULL
Reinberg	NULL
,	NULL
O.	NULL
Flores	NULL
,	NULL
C.	NULL
J.	NULL
Ingles	NULL
,	NULL
and	NULL
J.	NULL
Greenblatt	NULL
.	NULL

1994	NULL
.	NULL

Binding	NULL
of	NULL
basal	NULL
transcription	NULL
factor	NULL
TFIIH	NULL
to	NULL
the	NULL
acidic	NULL
activation	NULL
domains	NULL
of	NULL
VP16	NULL
and	NULL
p53	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

14:7013-7024	NULL
.	NULL

Xing	NULL
,	NULL
L.	NULL
,	NULL
V.	NULL
K.	NULL
Gopal	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Quinn	NULL
.	NULL

1995.	NULL
cAMP	NULL
response	NULL
clement-binding	NULL
protein	NULL
(	NULL
CREB	NULL
)	NULL
interacts	NULL
with	NULL
transcription	NULL
factors	NULL
IIB	NULL
and	NULL
IID	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:17488-17493	NULL
.	NULL

Yamashita	NULL
,	NULL
L.	NULL
,	NULL
S.	NULL
Katamine	NULL
,	NULL
R.	NULL
Moriuchi	NULL
,	NULL
Y.	NULL
Nakamura	NULL
,	NULL
T.	NULL
Miyamoto	NULL
,	NULL
K.	NULL
Eguchi	NULL
,	NULL
and	NULL
S.	NULL
Nagataki	NULL
.	NULL

1994	NULL
.	NULL

Transactivation	NULL
of	NULL
the	NULL
human	NULL
interleukin-6	NULL
104	NULL
.	NULL

105	NULL
.	NULL

106	NULL
.	NULL

107	NULL
.	NULL

108	NULL
.	NULL

109	NULL
.	NULL

110	NULL
.	NULL

111	NULL
.	NULL

112	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

gene	NULL
by	NULL
human	NULL
T-lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
Tax	NULL
protein	NULL
.	NULL

Blood	NULL
84:1573-1578	NULL
.	NULL

Yin	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
E.	NULL
Paulssen	NULL
,	NULL
J.	NULL
Seeler	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Gaynor	NULL
.	NULL

1995	NULL
.	NULL

Chimeric	NULL
proteins	NULL
composed	NULL
of	NULL
Jun	NULL
and	NULL
CREB	NULL
define	NULL
domains	NULL
required	NULL
for	NULL
interaction	NULL
with	NULL
the	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
Tax	NULL
protein	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:6209-6218	NULL
.	NULL

Yin	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
E.	NULL
J.	NULL
Paulssen	NULL
,	NULL
J.	NULL
S.	NULL
Seeler	NULL
,	NULL
and	NULL
R.	NULL
B.	NULL
Gaynor	NULL
.	NULL

1995	NULL
.	NULL

Protein	NULL
domains	NULL
involved	NULL
in	NULL
both	NULL
in	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
interactions	NULL
between	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
Tax	NULL
and	NULL
CREB	NULL
.	NULL

J.	NULL
Virol	NULL
.	NULL

69:3420-3432	NULL
.	NULL

Yokomori	NULL
,	NULL
K.	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
J	NULL
.	NULL

A.	NULL
Goodrich	NULL
,	NULL
J.	NULL
L.	NULL
Chen	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1993	NULL
.	NULL

Drosophilia	NULL
TFIIA-L	NULL
is	NULL
processed	NULL
into	NULL
two	NULL
subunits	NULL
that	NULL
are	NULL
associated	NULL
with	NULL
the	NULL
TBP/TAF	NULL
complex	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

7:2235-2245	NULL
.	NULL

Yokomori	NULL
,	NULL
K.	NULL
,	NULL
M.	NULL
P.	NULL
Zeidler	NULL
,	NULL
J.-L.	NULL
Chen	NULL
,	NULL
C.	NULL
P.	NULL
Verrijzer	NULL
,	NULL
M.	NULL
Mlodzik	NULL
,	NULL
and	NULL
R.	NULL
Tjian	NULL
.	NULL

1994	NULL
.	NULL

Drosophila	NULL
TFIIA	NULL
directs	NULL
cooperative	NULL
DNA	NULL
binding	NULL
with	NULL
TBP	NULL
and	NULL
mediates	NULL
transcriptional	NULL
activation	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

8:2313-2323	NULL
.	NULL

Yoshida	NULL
,	NULL
M.	NULL
,	NULL
M.	NULL
Seiki	NULL
,	NULL
K.	NULL
Yamaguchi	NULL
,	NULL
and	NULL
K.	NULL
Takatsuki	NULL
,	NULL
1984	NULL
.	NULL

Monoclonal	NULL
integration	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
provirus	NULL
in	NULL
all	NULL
primary	NULL
tumors	NULL
of	NULL
adult	NULL
T-cell	NULL
leukemia	NULL
suggests	NULL
a	NULL
causative	NULL
role	NULL
of	NULL
human	NULL
T-cell	NULL
leukemia	NULL
virus	NULL
in	NULL
disease	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
§1:2534-2537	NULL
.	NULL

Zawel	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
D.	NULL
Reinberg	NULL
.	NULL

1993	NULL
.	NULL

Initiation	NULL
of	NULL
transcription	NULL
by	NULL
RNA	NULL
polymerase	NULL
II	NULL
:	NULL
a	NULL
multi-step	NULL
process	NULL
.	NULL

Prog	NULL
.	NULL

Nucleic	NULL
Acid	NULL
Res	NULL
.	NULL

Mol	NULL
.	NULL

Biol	NULL
.	NULL

44:67-108	NULL
.	NULL

Zawel	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
D.	NULL
Reinberg	NULL
.	NULL

1995	NULL
.	NULL

Common	NULL
themes	NULL
in	NULL
assembly	NULL
and	NULL
function	NULL
of	NULL
eukaryotic	NULL
transcription	NULL
complexes	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Biochem	NULL
.	NULL

64:533-561	NULL
.	NULL

Zhao	NULL
,	NULL
L.-J	NULL
.	NULL

,	NULL
and	NULL
C.-Z	NULL
.	NULL

Giam	NULL
.	NULL

1992	NULL
.	NULL

Human	NULL
T-cell	NULL
lymphotropic	NULL
virus	NULL
type	NULL
I	NULL
(	NULL
HTLV-I	NULL
)	NULL
transcriptional	NULL
activator	NULL
,	NULL
Tax	NULL
,	NULL
enhances	NULL
CREB	NULL
binding	NULL
to	NULL
HTLV-I	NULL
21-base-pair	NULL
repeats	NULL
by	NULL
protein-protein	NULL
interaction	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:7070-7074	NULL
.	NULL

Zhu	NULL
,	NULL
H.	NULL
,	NULL
V.	NULL
Joliet	NULL
,	NULL
and	NULL
R.	NULL
Prywes	NULL
.	NULL

1994	NULL
.	NULL

Role	NULL
of	NULL
transcription	NULL
factor	NULL
TFIIF	NULL
in	NULL
serum	NULL
response	NULL
factor-activated	NULL
transcription	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:3489-3497	NULL
.	NULL

